-
1
-
-
2942648152
-
Schizophrenia
-
Mueser, K.; McGurk, S. Schizophrenia. The Lancet, 2004, 363, 2063-2072.
-
(2004)
The Lancet
, vol.363
, pp. 2063-2072
-
-
Mueser, K.1
McGurk, S.2
-
2
-
-
67650130341
-
When doors of perception close: Bottom-up models of disrupted cognition in schizophrenia
-
Javitt, D. C. When doors of perception close: Bottom-up models of disrupted cognition in schizophrenia. Annu. Rev. Clin. Psychol., 2009, 5, 249-275.
-
(2009)
Annu. Rev. Clin. Psychol
, vol.5
, pp. 249-275
-
-
Javitt, D.C.1
-
3
-
-
18744366088
-
Second-generation (atypical) antipsychotics and metabolic effects: A comprehensive literature review
-
Newcomer, J. W. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS drugs, 2005, 19 Suppl 1, 1-93.
-
(2005)
CNS Drugs
, vol.19
, Issue.SUPPL. 1
, pp. 1-93
-
-
Newcomer, J.W.1
-
4
-
-
0029918481
-
What are the functional consequences of neurocognitive deficits in schizophrenia?
-
Green, M. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry, 1996, 153, 321-330.
-
(1996)
Am. J. Psychiatry
, vol.153
, pp. 321-330
-
-
Green, M.1
-
5
-
-
34247643916
-
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial
-
Keefe, R. S.; Bilder, R. M.; Davis, S. M.; Harvey, P. D.; Palmer, B. W.; Gold, J. M.; Meltzer, H. Y.; Green, M. F.; Capuano, G.; Stroup, T. S.; McEvoy, J. P.; Swartz, M. S.; Rosenheck, R. A.; Perkins, D. O.; Davis, C. E.; Hsiao, J. K.; Lieberman, J. A. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch. Gen. Psychiatry, 2007, 64, 633-647.
-
(2007)
Arch. Gen. Psychiatry
, vol.64
, pp. 633-647
-
-
Keefe, R.S.1
Bilder, R.M.2
Davis, S.M.3
Harvey, P.D.4
Palmer, B.W.5
Gold, J.M.6
Meltzer, H.Y.7
Green, M.F.8
Capuano, G.9
Stroup, T.S.10
McEvoy, J.P.11
Swartz, M.S.12
Rosenheck, R.A.13
Perkins, D.O.14
Davis, C.E.15
Hsiao, J.K.16
Lieberman, J.A.17
-
6
-
-
0034843738
-
The emerging role of glutamate in the pathophysiology and treatment of schizophrenia
-
Goff, D. C.; Coyle, J. T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry, 2001, 158, 1367-1377.
-
(2001)
Am. J. Psychiatry
, vol.158
, pp. 1367-1377
-
-
Goff, D.C.1
Coyle, J.T.2
-
7
-
-
33749041047
-
Neurobiology of Schizophrenia
-
Ross, C.; Margolis, R.; Reading, S.; Pletnikov, M.; Coyle, J. Neurobiology of Schizophrenia. Neuron, 2006, 52, 139-153.
-
(2006)
Neuron
, vol.52
, pp. 139-153
-
-
Ross, C.1
Margolis, R.2
Reading, S.3
Pletnikov, M.4
Coyle, J.5
-
8
-
-
77952363301
-
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
-
Traynelis, S. F.; Wollmuth, L. P.; McBain, C. J.; Menniti, F. S.; Vance, K. M.; Ogden, K. K.; Hansen, K. B.; Yuan, H.; Myers, S. J.; Dingledine, R. Glutamate Receptor Ion Channels: Structure, Regulation, and Function. Pharmacol. Rev., 2010, 62, 405-496.
-
(2010)
Pharmacol. Rev
, vol.62
, pp. 405-496
-
-
Traynelis, S.F.1
Wollmuth, L.P.2
McBain, C.J.3
Menniti, F.S.4
Vance, K.M.5
Ogden, K.K.6
Hansen, K.B.7
Yuan, H.8
Myers, S.J.9
Dingledine, R.10
-
9
-
-
0032912771
-
The glutamate receptor ion channels
-
Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S. F. The glutamate receptor ion channels. Pharmacol. Rev., 1999, 51, 7-61.
-
(1999)
Pharmacol. Rev
, vol.51
, pp. 7-61
-
-
Dingledine, R.1
Borges, K.2
Bowie, D.3
Traynelis, S.F.4
-
10
-
-
0345830631
-
Physiological roles and therapeutic potential of metabotropic glutamate receptors
-
Conn, P. J. Physiological roles and therapeutic potential of metabotropic glutamate receptors. Ann. N Y Acad. Sci., 2003, 1003, 12-21.
-
(2003)
Ann. N Y Acad. Sci
, vol.1003
, pp. 12-21
-
-
Conn, P.J.1
-
11
-
-
17744387125
-
Ionotropic and metabotropic glutamate receptor structure and pharmacology
-
Kew, J. N. C.; Kemp, J. A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology, 2005, 179, 4-29.
-
(2005)
Psychopharmacology
, vol.179
, pp. 4-29
-
-
Kew, J.N.C.1
Kemp, J.A.2
-
12
-
-
0142095005
-
NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: Toward a paradigm shift in medication development
-
Krystal, J. H.; D'Souza, D. C.; Mathalon, D.; Perry, E.; Belger, A.; Hoffman, R. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology, 2003, 169, 215-233.
-
(2003)
Psychopharmacology
, vol.169
, pp. 215-233
-
-
Krystal, J.H.1
D'Souza, D.C.2
Mathalon, D.3
Perry, E.4
Belger, A.5
Hoffman, R.6
-
13
-
-
0032694066
-
NMDA receptor hypofunction model of schizophrenia
-
Olney, J. W.; Newcomer, J. W.; Farber, N. B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res., 1999, 33, 523-533.
-
(1999)
J. Psychiatr. Res
, vol.33
, pp. 523-533
-
-
Olney, J.W.1
Newcomer, J.W.2
Farber, N.B.3
-
14
-
-
79955745328
-
Glutamate: New hope for schizophrenia therapy
-
Kantrowitz, E. R.; Javitt, D. Glutamate: New hope for schizophrenia therapy. Current Psychiatry, 2011, 10, 69-74.
-
(2011)
Current Psychiatry
, vol.10
, pp. 69-74
-
-
Kantrowitz, E.R.1
Javitt, D.2
-
15
-
-
84855927044
-
Targeting glutamate synapses in schizophrenia
-
Field, J. R.; Walker, A. G.; Conn, P. J. Targeting glutamate synapses in schizophrenia. Trends Mol. Med., 2011, 17, 689-698.
-
(2011)
Trends Mol. Med
, vol.17
, pp. 689-698
-
-
Field, J.R.1
Walker, A.G.2
Conn, P.J.3
-
16
-
-
84870064466
-
Neurodevelopmental model of schizophrenia: Update 2012
-
Rapoport, J. L.; Giedd, J. N.; Gogtay, N. Neurodevelopmental model of schizophrenia: update 2012. Mol. Psychiatry, 2012, 17, 1228-1238.
-
(2012)
Mol. Psychiatry
, vol.17
, pp. 1228-1238
-
-
Rapoport, J.L.1
Giedd, J.N.2
Gogtay, N.3
-
17
-
-
79952213956
-
Neurodevelopmental hypothesis of schizophrenia
-
Owen, M. J.; O'Donovan, M. C.; Thapar, A.; Craddock, N. Neurodevelopmental hypothesis of schizophrenia. Br. J. Psychiatry, 2011, 198, 173-175.
-
(2011)
Br. J. Psychiatry
, vol.198
, pp. 173-175
-
-
Owen, M.J.1
O'Donovan, M.C.2
Thapar, A.3
Craddock, N.4
-
18
-
-
33646680756
-
Neurocognitive performance and functional disability in the psychosis prodrome
-
Niendam, T.; Bearden, C.; Johnson, J.; McKinley, M.; Loewy, R.; Obrien, M.; Nuechterlein, K.; Green, M.; Cannon, T. Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr. Res., 2006, 84, 100-111.
-
(2006)
Schizophr. Res
, vol.84
, pp. 100-111
-
-
Niendam, T.1
Bearden, C.2
Johnson, J.3
McKinley, M.4
Loewy, R.5
Obrien, M.6
Nuechterlein, K.7
Green, M.8
Cannon, T.9
-
19
-
-
33748474553
-
Pathophysiologically based treatment interventions in schizophrenia
-
Lewis, D. A.; Gonzalez-Burgos, G. Pathophysiologically based treatment interventions in schizophrenia. Nat. Med., 2006, 12, 1016-1022.
-
(2006)
Nat. Med
, vol.12
, pp. 1016-1022
-
-
Lewis, D.A.1
Gonzalez-Burgos, G.2
-
20
-
-
16344372645
-
Cortical inhibitory neurons and schizophrenia
-
Lewis, D. A.; Hashimoto, T.; Volk, D. W. Cortical inhibitory neurons and schizophrenia. Nat. Rev.Neurosci., 2005, 6, 312-324.
-
(2005)
Nat. Rev.Neurosci
, vol.6
, pp. 312-324
-
-
Lewis, D.A.1
Hashimoto, T.2
Volk, D.W.3
-
21
-
-
84856857477
-
Cortical basket cell dysfunction in schizophrenia
-
Curley, A. A.; Lewis, D. A. Cortical basket cell dysfunction in schizophrenia. J. Physiol., 2012, 590, 715-724.
-
(2012)
J. Physiol
, vol.590
, pp. 715-724
-
-
Curley, A.A.1
Lewis, D.A.2
-
22
-
-
80051782825
-
Selective Pyramidal Cell Reduction of GABA(A) Receptor alpha1 Subunit Messenger RNA Expression in Schizophrenia
-
Glausier, J. R.; Lewis, D. A. Selective Pyramidal Cell Reduction of GABA(A) Receptor alpha1 Subunit Messenger RNA Expression in Schizophrenia. Neuropsychopharmacology, 2011, 36, 2103-2110.
-
(2011)
Neuropsychopharmacology
, vol.36
, pp. 2103-2110
-
-
Glausier, J.R.1
Lewis, D.A.2
-
23
-
-
84863201711
-
NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons and Cortical Gamma Oscillations in Schizophrenia
-
Gonzalez-Burgos, G.; Lewis, D. A. NMDA Receptor Hypofunction, Parvalbumin-Positive Neurons and Cortical Gamma Oscillations in Schizophrenia. Schizophr. Bull., 2012, 38, 950-957.
-
(2012)
Schizophr. Bull
, vol.38
, pp. 950-957
-
-
Gonzalez-Burgos, G.1
Lewis, D.A.2
-
24
-
-
77950669072
-
Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia
-
Torkamani, A.; Dean, B.; Schork, N. J.; Thomas, E. A. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res., 2010, 20, 403-412.
-
(2010)
Genome Res
, vol.20
, pp. 403-412
-
-
Torkamani, A.1
Dean, B.2
Schork, N.J.3
Thomas, E.A.4
-
25
-
-
84866372949
-
Convergent functional genomics of schizophrenia: From comprehensive understanding to genetic risk prediction
-
Ayalew, M.; Le-Niculescu, H.; Levey, D. F.; Jain, N.; Changala, B.; Patel, S. D.; Winiger, E.; Breier, A.; Shekhar, A.; Amdur, R.; Koller, D.; Nurnberger, J. I.; Corvin, A.; Geyer, M.; Tsuang, M. T.; Salomon, D.; Schork, N. J.; Fanous, A. H.; O'Donovan, M. C.; Niculescu, A. B. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol. Psychiatry, 2012, 17, 887-905.
-
(2012)
Mol. Psychiatry
, vol.17
, pp. 887-905
-
-
Ayalew, M.1
Le-Niculescu, H.2
Levey, D.F.3
Jain, N.4
Changala, B.5
Patel, S.D.6
Winiger, E.7
Breier, A.8
Shekhar, A.9
Amdur, R.10
Koller, D.11
Nurnberger, J.I.12
Corvin, A.13
Geyer, M.14
Tsuang, M.T.15
Salomon, D.16
Schork, N.J.17
Fanous, A.H.18
O'Donovan, M.C.19
Niculescu, A.B.20
more..
-
26
-
-
77955621530
-
Genes and environment: Multiple pathways to psychopathology
-
Mann, J. J.; Haghighi, F. Genes and environment: multiple pathways to psychopathology. Biol. Psychiatry, 2010, 68, 403-404.
-
(2010)
Biol. Psychiatry
, vol.68
, pp. 403-404
-
-
Mann, J.J.1
Haghighi, F.2
-
27
-
-
0033956237
-
Schizophrenia: Genes and environment
-
Tsuang, M. Schizophrenia: genes and environment. Biol. Psychiatry, 2000, 47, 210-220.
-
(2000)
Biol. Psychiatry
, vol.47
, pp. 210-220
-
-
Tsuang, M.1
-
28
-
-
84856706805
-
Puzzling over schizophrenia: Schizophrenia as a pathway disease
-
Sullivan, P. F. Puzzling over schizophrenia: schizophrenia as a pathway disease. Nat. Med., 2012, 18, 210-211.
-
(2012)
Nat. Med
, vol.18
, pp. 210-211
-
-
Sullivan, P.F.1
-
29
-
-
84865790047
-
An integrated encyclopedia of DNA elements in the human genome
-
Bernstein, B. E.; Birney, E.; Dunham, I.; Green, E. D.; Gunter, C.; Snyder, M. An integrated encyclopedia of DNA elements in the human genome. Nature, 2012, 489, 57-74.
-
(2012)
Nature
, vol.489
, pp. 57-74
-
-
Bernstein, B.E.1
Birney, E.2
Dunham, I.3
Green, E.D.4
Gunter, C.5
Snyder, M.6
-
30
-
-
84865755978
-
The accessible chromatin landscape of the human genome
-
Thurman, R. E.; Rynes, E.; Humbert, R.; Vierstra, J.; Maurano, M. T.; Haugen, E.; Sheffield, N. C.; Stergachis, A. B.; Wang, H.; Vernot, B.; Garg, K.; John, S.; Sandstrom, R.; Bates, D.; Boatman, L.; Canfield, T. K.; Diegel, M.; Dunn, D.; Ebersol, A. K.; Frum, T.; Giste, E.; Johnson, A. K.; Johnson, E. M.; Kutyavin, T.; Lajoie, B.; Lee, B. K.; Lee, K.; London, D.; Lotakis, D.; Neph, S.; Neri, F.; Nguyen, E. D.; Qu, H.; Reynolds, A. P.; Roach, V.; Safi, A.; Sanchez, M. E.; Sanyal, A.; Shafer, A.; Simon, J. M.; Song, L.; Vong, S.; Weaver, M.; Yan, Y.; Zhang, Z.; Lenhard, B.; Tewari, M.; Dorschner, M. O.; Hansen, R. S.; Navas, P. A.; Stamatoyannopoulos, G.; Iyer, V. R.; Lieb, J. D.; Sunyaev, S. R.; Akey, J. M.; Sabo, P. J.; Kaul, R.; Furey, T. S.; Dekker, J.; Crawford, G. E.; Stamatoyannopoulos, J. A. The accessible chromatin landscape of the human genome. Nature, 2012, 489, 75-82.
-
(2012)
Nature
, vol.489
, pp. 75-82
-
-
Thurman, R.E.1
Rynes, E.2
Humbert, R.3
Vierstra, J.4
Maurano, M.T.5
Haugen, E.6
Sheffield, N.C.7
Stergachis, A.B.8
Wang, H.9
Vernot, B.10
Garg, K.11
John, S.12
Sandstrom, R.13
Bates, D.14
Boatman, L.15
Canfield, T.K.16
Diegel, M.17
Dunn, D.18
Ebersol, A.K.19
Frum, T.20
Giste, E.21
Johnson, A.K.22
Johnson, E.M.23
Kutyavin, T.24
Lajoie, B.25
Lee, B.K.26
Lee, K.27
London, D.28
Lotakis, D.29
Neph, S.30
Neri, F.31
Nguyen, E.D.32
Qu, H.33
Reynolds, A.P.34
Roach, V.35
Safi, A.36
Sanchez, M.E.37
Sanyal, A.38
Shafer, A.39
Simon, J.M.40
Song, L.41
Vong, S.42
Weaver, M.43
Yan, Y.44
Zhang, Z.45
Lenhard, B.46
Tewari, M.47
Dorschner, M.O.48
Hansen, R.S.49
Navas, P.A.50
Stamatoyannopoulos, G.51
Iyer, V.R.52
Lieb, J.D.53
Sunyaev, S.R.54
Akey, J.M.55
Sabo, P.J.56
Kaul, R.57
Furey, T.S.58
Dekker, J.59
Crawford, G.E.60
Stamatoyannopoulos, J.A.61
more..
-
31
-
-
84866736529
-
Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia
-
Lips, E. S.; Cornelisse, L. N.; Toonen, R. F.; Min, J. L.; Hultman, C. M.; Holmans, P. A.; O'Donovan, M. C.; Purcell, S. M.; Smit, A. B.; Verhage, M.; Sullivan, P. F.; Visscher, P. M.; Posthuma, D. Functional gene group analysis identifies synaptic gene groups as risk factor for schizophrenia. Mol. Psychiatry, 2012, 17, 996-1006.
-
(2012)
Mol. Psychiatry
, vol.17
, pp. 996-1006
-
-
Lips, E.S.1
Cornelisse, L.N.2
Toonen, R.F.3
Min, J.L.4
Hultman, C.M.5
Holmans, P.A.6
O'Donovan, M.C.7
Purcell, S.M.8
Smit, A.B.9
Verhage, M.10
Sullivan, P.F.11
Visscher, P.M.12
Posthuma, D.13
-
32
-
-
77951636682
-
Gene-and evidence-based candidate gene selection for schizophrenia and gene feature analysis
-
Sun, J.; Han, L.; Zhao, Z. Gene-and evidence-based candidate gene selection for schizophrenia and gene feature analysis. Artif. Intell. Med., 2010, 48, 99-106.
-
(2010)
Artif. Intell. Med
, vol.48
, pp. 99-106
-
-
Sun, J.1
Han, L.2
Zhao, Z.3
-
33
-
-
70349884348
-
A multidimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case
-
Sun, J.; Jia, P.; Fanous, A. H.; Webb, B. T.; van den Oord, E. J.; Chen, X.; Bukszar, J.; Kendler, K. S.; Zhao, Z. A multidimensional evidence-based candidate gene prioritization approach for complex diseases-schizophrenia as a case. Bioinformatics, 2009, 25, 2595-6602.
-
(2009)
Bioinformatics
, vol.25
, pp. 2595-6602
-
-
Sun, J.1
Jia, P.2
Fanous, A.H.3
Webb, B.T.4
van den Oord, E.J.5
Chen, X.6
Bukszar, J.7
Kendler, K.S.8
Zhao, Z.9
-
34
-
-
77949540980
-
SZGR: A comprehensive schizophrenia gene resource
-
Jia, P.; Sun, J.; Guo, A. Y.; Zhao, Z. SZGR: a comprehensive schizophrenia gene resource. Mol. Psychiatry, 2010, 15, 453-462.
-
(2010)
Mol. Psychiatry
, vol.15
, pp. 453-462
-
-
Jia, P.1
Sun, J.2
Guo, A.Y.3
Zhao, Z.4
-
35
-
-
84555189458
-
An integrative functional genomics approach for discovering biomarkers in schizophrenia
-
Vawter, M. P.; Mamdani, F.; Macciardi, F. An integrative functional genomics approach for discovering biomarkers in schizophrenia. Brief Funct. Genomics, 2011, 10, 387-399.
-
(2011)
Brief Funct. Genomics
, vol.10
, pp. 387-399
-
-
Vawter, M.P.1
Mamdani, F.2
Macciardi, F.3
-
36
-
-
77955340562
-
Schizophrenia gene networks and pathways and their applications for novel candidate gene selection
-
Sun, J.; Jia, P.; Fanous, A. H.; van den Oord, E.; Chen, X.; Riley, B. P.; Amdur, R. L.; Kendler, K. S.; Zhao, Z. Schizophrenia gene networks and pathways and their applications for novel candidate gene selection. PLoS One 2010, 5, e11351.
-
(2010)
PLoS One
, vol.5
-
-
Sun, J.1
Jia, P.2
Fanous, A.H.3
van den Oord, E.4
Chen, X.5
Riley, B.P.6
Amdur, R.L.7
Kendler, K.S.8
Zhao, Z.9
-
37
-
-
84864033725
-
Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression
-
Lee, S. A.; Tsao, T. T.; Yang, K. C.; Lin, H.; Kuo, Y. L.; Hsu, C. H.; Lee, W. K.; Huang, K. C.; Kao, C. Y. Construction and analysis of the protein-protein interaction networks for schizophrenia, bipolar disorder, and major depression. BMC Bioinformatics, 2011, 12 Suppl 13, S20.
-
(2011)
BMC Bioinformatics
, vol.12
, Issue.SUPPL. 13
-
-
Lee, S.A.1
Tsao, T.T.2
Yang, K.C.3
Lin, H.4
Kuo, Y.L.5
Hsu, C.H.6
Lee, W.K.7
Huang, K.C.8
Kao, C.Y.9
-
38
-
-
84862992566
-
A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes
-
de Jong, S.; Boks, M. P.; Fuller, T. F.; Strengman, E.; Janson, E.; de Kovel, C. G.; Ori, A. P.; Vi, N.; Mulder, F.; Blom, J. D.; Glenthøj, B.; Schubart, C. D.; Cahn, W.; Kahn, R. S.; Horvath, S.; Ophoff, R. A. A gene co-expression network in whole blood of schizophrenia patients is independent of antipsychotic-use and enriched for brain-expressed genes. PLoS One, 2012, 7, e39498.
-
(2012)
PLoS One
, vol.7
-
-
de Jong, S.1
Boks, M.P.2
Fuller, T.F.3
Strengman, E.4
Janson, E.5
de Kovel, C.G.6
Ori, A.P.7
Vi, N.8
Mulder, F.9
Blom, J.D.10
Glenthøj, B.11
Schubart, C.D.12
Cahn, W.13
Kahn, R.S.14
Horvath, S.15
Ophoff, R.A.16
-
39
-
-
80053131124
-
Large-scale brain networks and psychopathology: A unifying triple network model
-
Menon, V. Large-scale brain networks and psychopathology: a unifying triple network model. Trends Cogn. Sci., 2011, 15, 483-506.
-
(2011)
Trends Cogn. Sci
, vol.15
, pp. 483-506
-
-
Menon, V.1
-
40
-
-
79952680751
-
Dysfunctional brain networks and genetic risk for schizophrenia: Specific neurotransmitter systems
-
Hirvonen, J.; Hietala, J. Dysfunctional brain networks and genetic risk for schizophrenia: specific neurotransmitter systems. CNS Neurosci. Ther., 2011, 17, 89-96.
-
(2011)
CNS Neurosci. Ther
, vol.17
, pp. 89-96
-
-
Hirvonen, J.1
Hietala, J.2
-
41
-
-
78649906486
-
Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia
-
Balu, D. T.; Coyle, J. T. Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia. Neurosci. Biobehav. Rev., 2011, 35, 848-870.
-
(2011)
Neurosci. Biobehav. Rev
, vol.35
, pp. 848-870
-
-
Balu, D.T.1
Coyle, J.T.2
-
42
-
-
77956647781
-
The neuregulin signaling pathway and schizophrenia: From genes to synapses and neural circuits
-
Buonanno, A. The neuregulin signaling pathway and schizophrenia: from genes to synapses and neural circuits. Brain Res. Bull., 2010, 83, 122-131.
-
(2010)
Brain Res. Bull
, vol.83
, pp. 122-131
-
-
Buonanno, A.1
-
43
-
-
77956648156
-
N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: The final common pathway on the road to schizophrenia?
-
Kantrowitz, J. T.; Javitt, D. C. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res. Bull., 2010, 83, 108-121.
-
(2010)
Brain Res. Bull
, vol.83
, pp. 108-121
-
-
Kantrowitz, J.T.1
Javitt, D.C.2
-
44
-
-
0029162231
-
Subanesthetic doses of ketamine stimulate psychosis in schizophrenia
-
Lahti, A. C.; Koffel, B.; LaPorte, D.; Tamminga, C. A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology, 1995, 13, 9-19.
-
(1995)
Neuropsychopharmacology
, vol.13
, pp. 9-19
-
-
Lahti, A.C.1
Koffel, B.2
Laporte, D.3
Tamminga, C.A.4
-
45
-
-
0030749913
-
Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics
-
Malhotra, A. K.; Pinals, D. A.; Adler, C. M.; Elman, I.; Clifton, A.; Pickar, D.; Breier, A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology, 1997, 17, 141-150.
-
(1997)
Neuropsychopharmacology
, vol.17
, pp. 141-150
-
-
Malhotra, A.K.1
Pinals, D.A.2
Adler, C.M.3
Elman, I.4
Clifton, A.5
Pickar, D.6
Breier, A.7
-
46
-
-
84866640784
-
Phencyclidine/Schizophrenia: One View Toward the Past, The Other to the Future
-
Domino, E. F.; Luby, E. D. Phencyclidine/Schizophrenia: One View Toward the Past, The Other to the Future. Schizophr. Bull., 2012, 38, 914-919.
-
(2012)
Schizophr. Bull
, vol.38
, pp. 914-919
-
-
Domino, E.F.1
Luby, E.D.2
-
47
-
-
30844439634
-
Glutamate-based therapeutic approaches: Clinical trials with NMDA antagonists
-
Muir, K. W. Glutamate-based therapeutic approaches: clinical trials with NMDA antagonists. Curr. Opin. Pharmacol., 2006, 6, 53-60.
-
(2006)
Curr. Opin. Pharmacol
, vol.6
, pp. 53-60
-
-
Muir, K.W.1
-
48
-
-
0032824132
-
Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke
-
Dyker, A. G.; Edwards, K. R.; Fayad, P. B.; Hormes, J. T.; Lees, K. R. Safety and tolerability study of aptiganel hydrochloride in patients with an acute ischemic stroke. Stroke, 1999, 30, 2038-2042.
-
(1999)
Stroke
, vol.30
, pp. 2038-2042
-
-
Dyker, A.G.1
Edwards, K.R.2
Fayad, P.B.3
Hormes, J.T.4
Lees, K.R.5
-
49
-
-
0029555515
-
Clinical pharmacology of CNS 1102 in volunteers
-
discussion 298
-
Muir, K. W.; Grosset, D. G.; Lees, K. R. Clinical pharmacology of CNS 1102 in volunteers. Ann. N Y Acad. Sci., 1995, 765, 279-289; discussion 298.
-
(1995)
Ann. N Y Acad. Sci
, vol.765
, pp. 279-289
-
-
Muir, K.W.1
Grosset, D.G.2
Lees, K.R.3
-
51
-
-
0032103160
-
Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers
-
Adler, C. M.; Goldberg, T. E.; Malhotra, A. K.; Pickar, D.; Breier, A. Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers. Biol. Psychiatry, 1998, 43, 811-816.
-
(1998)
Biol. Psychiatry
, vol.43
, pp. 811-816
-
-
Adler, C.M.1
Goldberg, T.E.2
Malhotra, A.K.3
Pickar, D.4
Breier, A.5
-
52
-
-
0032859516
-
Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia
-
Adler, C. M.; Malhotra, A. K.; Elman, I.; Goldberg, T.; Egan, M.; Pickar, D.; Breier, A. Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in schizophrenia. Am. J. Psychiatry, 1999, 156, 1646-1649.
-
(1999)
Am. J. Psychiatry
, vol.156
, pp. 1646-1649
-
-
Adler, C.M.1
Malhotra, A.K.2
Elman, I.3
Goldberg, T.4
Egan, M.5
Pickar, D.6
Breier, A.7
-
53
-
-
0030966452
-
Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers
-
Breier, A.; Malhotra, A. K.; Pinals, D. A.; Weisenfeld, N. I.; Pickar, D. Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers. Am. J. Psychiatry, 1997, 154, 805-811.
-
(1997)
Am. J. Psychiatry
, vol.154
, pp. 805-811
-
-
Breier, A.1
Malhotra, A.K.2
Pinals, D.A.3
Weisenfeld, N.I.4
Pickar, D.5
-
54
-
-
0029927565
-
NMDA receptor function and human cognition: The effects of ketamine in healthy volunteers
-
Malhotra, A. K.; Pinals, D. A.; Weingartner, H.; Sirocco, K.; Missar, C. D.; Pickar, D.; Breier, A. NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers. Neuropsychopharmacology, 1996, 14, 301-307.
-
(1996)
Neuropsychopharmacology
, vol.14
, pp. 301-307
-
-
Malhotra, A.K.1
Pinals, D.A.2
Weingartner, H.3
Sirocco, K.4
Missar, C.D.5
Pickar, D.6
Breier, A.7
-
55
-
-
0028323167
-
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual cognitive, and neuroendocrine responses
-
Krystal, J. H.; Karper, L. P.; Seibyl, J. P.; Freeman, G. K.; Delaney, R.; Bremner, J. D.; Heninger, G. R.; Bowers, M. B., Jr.; Charney, D. S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry, 1994, 51, 199-214.
-
(1994)
Arch. Gen. Psychiatry
, vol.51
, pp. 199-214
-
-
Krystal, J.H.1
Karper, L.P.2
Seibyl, J.P.3
Freeman, G.K.4
Delaney, R.5
Bremner, J.D.6
Heninger, G.R.7
Bowers Jr., M.B.8
Charney, D.S.9
-
56
-
-
46749113023
-
Individual Differences in Psychotic Effects of Ketamine Are Predicted by Brain Function Measured under Placebo
-
Honey, G. D.; Corlett, P. R.; Absalom, A. R.; Lee, M.; Pomarol-Clotet, E.; Murray, G. K.; McKenna, P. J.; Bullmore, E. T.; Menon, D. K.; Fletcher, P. C. Individual Differences in Psychotic Effects of Ketamine Are Predicted by Brain Function Measured under Placebo. J. Neurosci., 2008, 28, 6295-6303.
-
(2008)
J. Neurosci
, vol.28
, pp. 6295-6303
-
-
Honey, G.D.1
Corlett, P.R.2
Absalom, A.R.3
Lee, M.4
Pomarol-Clotet, E.5
Murray, G.K.6
McKenna, P.J.7
Bullmore, E.T.8
Menon, D.K.9
Fletcher, P.C.10
-
57
-
-
30944451560
-
The Effects of a Subpsychotic Dose of Ketamine on Recognition and Source Memory for Agency: Implications for Pharmacological Modelling of Core Symptoms of Schizophrenia
-
Honey, G. D.; O'Loughlin, C.; Turner, D. C.; Pomarol-Clotet, E.; Corlett, P. R.; Fletcher, P. C. The Effects of a Subpsychotic Dose of Ketamine on Recognition and Source Memory for Agency: Implications for Pharmacological Modelling of Core Symptoms of Schizophrenia. Neuropsychopharmacology, 2005, 31, 413-423.
-
(2005)
Neuropsychopharmacology
, vol.31
, pp. 413-423
-
-
Honey, G.D.1
O'Loughlin, C.2
Turner, D.C.3
Pomarol-Clotet, E.4
Corlett, P.R.5
Fletcher, P.C.6
-
58
-
-
84866674097
-
Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia
-
Javitt, D. C.; Zukin, S. R.; Heresco-Levy, U.; Umbricht, D. Has an Angel Shown the Way? Etiological and Therapeutic Implications of the PCP/NMDA Model of Schizophrenia. Schizophr. Bull., 2012, 38, 958-966.
-
(2012)
Schizophr. Bull
, vol.38
, pp. 958-966
-
-
Javitt, D.C.1
Zukin, S.R.2
Heresco-Levy, U.3
Umbricht, D.4
-
59
-
-
73949124536
-
Sensory processing in schizophrenia: Neither simple nor intact
-
Javitt, D. C. Sensory processing in schizophrenia: neither simple nor intact. Schizophr. Bull., 2009, 35, 1059-1064.
-
(2009)
Schizophr. Bull
, vol.35
, pp. 1059-1064
-
-
Javitt, D.C.1
-
60
-
-
77149138329
-
Glutamatergic (N-Methyl-D-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain
-
Marek, G. J.; Behl, B.; Bespalov, A. Y.; Gross, G.; Lee, Y.; Schoemaker, H. Glutamatergic (N-Methyl-D-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain? Mol. Pharmacol., 2009, 77, 317-326.
-
(2009)
Mol. Pharmacol
, vol.77
, pp. 317-326
-
-
Marek, G.J.1
Behl, B.2
Bespalov, A.Y.3
Gross, G.4
Lee, Y.5
Schoemaker, H.6
-
61
-
-
0034600485
-
Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: A randomised controlled trial. GAIN International Investigators
-
Lees, K. R.; Asplund, K.; Carolei, A.; Davis, S. M.; Diener, H. C.; Kaste, M.; Orgogozo, J. M.; Whitehead, J. Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet, 2000, 355, 1949-1954.
-
(2000)
Lancet
, vol.355
, pp. 1949-1954
-
-
Lees, K.R.1
Asplund, K.2
Carolei, A.3
Davis, S.M.4
Diener, H.C.5
Kaste, M.6
Orgogozo, J.M.7
Whitehead, J.8
-
62
-
-
0035804844
-
Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: A randomized controlled trial
-
Sacco, R. L.; DeRosa, J. T.; Haley, E. C., Jr.; Levin, B.; Ordronneau, P.; Phillips, S. J.; Rundek, T.; Snipes, R. G.; Thompson, J. L. Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. JAMA, 2001, 285, 1719-1728.
-
(2001)
JAMA
, vol.285
, pp. 1719-1728
-
-
Sacco, R.L.1
Derosa, J.T.2
Haley Jr., E.C.3
Levin, B.4
Ordronneau, P.5
Phillips, S.J.6
Rundek, T.7
Snipes, R.G.8
Thompson, J.L.9
-
63
-
-
57049160908
-
Effects of a GLUN2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism
-
Nutt, J. G.; Gunzler, S. A.; Kirchhoff, T.; Hogarth, P.; Weaver, J. L.; Krams, M.; Jamerson, B.; Menniti, F. S.; Landen, J. W. Effects of a GLUN2B selective NMDA glutamate antagonist, CP-101,606, on dyskinesia and Parkinsonism. Mov. Disord., 2008, 23, 1860-1866.
-
(2008)
Mov. Disord
, vol.23
, pp. 1860-1866
-
-
Nutt, J.G.1
Gunzler, S.A.2
Kirchhoff, T.3
Hogarth, P.4
Weaver, J.L.5
Krams, M.6
Jamerson, B.7
Menniti, F.S.8
Landen, J.W.9
-
64
-
-
59049098262
-
An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder
-
Preskorn, S. H.; Baker, B. R.; Kolluri, S.; Menniti, F. S.; Krams, M.; Landen, J. W. An Innovative Design to Establish Proof of Concept of the Antidepressant Effects of the NR2B Subunit Selective N-Methyl-D-Aspartate Antagonist, CP-101,606, in Patients With Treatment-Refractory Major Depressive Disorder. J. Clin. Psychopharmacol., 2008, 28, 631-637.
-
(2008)
J. Clin. Psychopharmacol
, vol.28
, pp. 631-637
-
-
Preskorn, S.H.1
Baker, B.R.2
Kolluri, S.3
Menniti, F.S.4
Krams, M.5
Landen, J.W.6
-
65
-
-
4444252518
-
The GLUN2B subunit-selective NMDA receptor antagonist CP-101,606 reduces pain intensity in patients with central and peripheral neuropathic pain
-
New Orleans, LA
-
Sang, C. N.; Weaver, J. J.; Jinga, L.; Wouden, J.; Saltarelli, M. D. (2003) The GLUN2B subunit-selective NMDA receptor antagonist CP-101,606 reduces pain intensity in patients with central and peripheral neuropathic pain in Society for Neuroscience, p 814-819, New Orleans, LA.
-
(2003)
Society For Neuroscience
, pp. 814-819
-
-
Sang, C.N.1
Weaver, J.J.2
Jinga, L.3
Wouden, J.4
Saltarelli, M.D.5
-
66
-
-
82955236070
-
A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory
-
Smith, J. W.; Gastambide, F.; Gilmour, G.; Dix, S.; Foss, J.; Lloyd, K.; Malik, N.; Tricklebank, M. A comparison of the effects of ketamine and phencyclidine with other antagonists of the NMDA receptor in rodent assays of attention and working memory. Psychopharmacology, 2011, 217, 255-269.
-
(2011)
Psychopharmacology
, vol.217
, pp. 255-269
-
-
Smith, J.W.1
Gastambide, F.2
Gilmour, G.3
Dix, S.4
Foss, J.5
Lloyd, K.6
Malik, N.7
Tricklebank, M.8
-
67
-
-
77957335007
-
A within-subject cognitive battery in the rat: Differential effects of NMDA receptor antagonists
-
Dix, S.; Gilmour, G.; Potts, S.; Smith, J. W.; Tricklebank, M. A within-subject cognitive battery in the rat: differential effects of NMDA receptor antagonists. Psychopharmacology, 2010, 212, 227-242.
-
(2010)
Psychopharmacology
, vol.212
, pp. 227-242
-
-
Dix, S.1
Gilmour, G.2
Potts, S.3
Smith, J.W.4
Tricklebank, M.5
-
68
-
-
67649964302
-
Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: Implications for "NMDA antagonist modelling" of schizophrenia
-
Gilmour, G.; Pioli, E. Y.; Dix, S. L.; Smith, J. W.; Conway, M. W.; Jones, W. T.; Loomis, S.; Mason, R.; Shahabi, S.; Tricklebank, M. D. Diverse and often opposite behavioural effects of NMDA receptor antagonists in rats: implications for "NMDA antagonist modelling" of schizophrenia. Psychopharmacology, 2009, 205, 203-216.
-
(2009)
Psychopharmacology
, vol.205
, pp. 203-216
-
-
Gilmour, G.1
Pioli, E.Y.2
Dix, S.L.3
Smith, J.W.4
Conway, M.W.5
Jones, W.T.6
Loomis, S.7
Mason, R.8
Shahabi, S.9
Tricklebank, M.D.10
-
69
-
-
0141757281
-
Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: Preferential involvement of the NR2B rather than NR2A subunit
-
Chaperon, F.; Muller, W.; Auberson, Y. P.; Tricklebank, M. D.; Neijt, H. C. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit. Behav. Pharmacol., 2003, 14, 477-487.
-
(2003)
Behav. Pharmacol
, vol.14
, pp. 477-487
-
-
Chaperon, F.1
Muller, W.2
Auberson, Y.P.3
Tricklebank, M.D.4
Neijt, H.C.5
-
70
-
-
62449107334
-
The discriminative stimulus effects of N-methyl-d-aspartate glycine-site ligands in NMDA antagonisttrained rats
-
Nicholson, K. L.; Balster, R. L. The discriminative stimulus effects of N-methyl-d-aspartate glycine-site ligands in NMDA antagonisttrained rats. Psychopharmacology, 2009, 203, 441-451.
-
(2009)
Psychopharmacology
, vol.203
, pp. 441-451
-
-
Nicholson, K.L.1
Balster, R.L.2
-
71
-
-
35948933040
-
The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101,606 in rats and rhesus monkeys
-
Nicholson, K. L.; Mansbach, R. S.; Menniti, F. S.; Balster, R. L. The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101,606 in rats and rhesus monkeys. Behav. Pharmacol., 2007, 18, 731-743.
-
(2007)
Behav. Pharmacol
, vol.18
, pp. 731-743
-
-
Nicholson, K.L.1
Mansbach, R.S.2
Menniti, F.S.3
Balster, R.L.4
-
72
-
-
33749074397
-
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
-
Coyle, J. T. Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis. Cell. Mol. Neurobiol., 2006, 26, 363-382.
-
(2006)
Cell. Mol. Neurobiol
, vol.26
, pp. 363-382
-
-
Coyle, J.T.1
-
73
-
-
42749095376
-
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia
-
Lisman, J.; Coyle, J.; Green, R.; Javitt, D.; Benes, F.; Heckers, S.; Grace, A. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci., 2008, 31, 234-242.
-
(2008)
Trends Neurosci
, vol.31
, pp. 234-242
-
-
Lisman, J.1
Coyle, J.2
Green, R.3
Javitt, D.4
Benes, F.5
Heckers, S.6
Grace, A.7
-
74
-
-
79959207825
-
Neurobiological background for the development of new drugs in schizophrenia
-
Lopez-Munoz, F.; Alamo, C. Neurobiological background for the development of new drugs in schizophrenia. Clin. Neuropharmacol., 2011, 34, 111-126.
-
(2011)
Clin. Neuropharmacol
, vol.34
, pp. 111-126
-
-
Lopez-Munoz, F.1
Alamo, C.2
-
75
-
-
0034811597
-
Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system
-
Schoepp, D.D. Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system. J. Pharmacol. Exp. Ther., 2001, 299, 12-20.
-
(2001)
J. Pharmacol. Exp. Ther
, vol.299
, pp. 12-20
-
-
Schoepp, D.D.1
-
76
-
-
34447638166
-
Allosteric enhancers, allosteric agonists and ago-allosteric modulators: Where do they bind and how do they act?
-
Schwartz, T. W.; Holst, B. Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? Trends Pharmacol. Sci., 2007, 28, 366-373.
-
(2007)
Trends Pharmacol. Sci
, vol.28
, pp. 366-373
-
-
Schwartz, T.W.1
Holst, B.2
-
77
-
-
79953899942
-
Allosteric modulation of family C G-protein-coupled receptors: From molecular insights to therapeutic perspectives
-
Urwyler, S. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives. Pharmacol. Rev., 2011, 63, 59-126.
-
(2011)
Pharmacol. Rev
, vol.63
, pp. 59-126
-
-
Urwyler, S.1
-
78
-
-
58149193205
-
Allosteric modulators of GPCRs: A novel approach for the treatment of CNS disorders
-
Conn, J. P.; Christopoulus, A.; Lindsley, C. W. Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders. Nat. Rev. Drug Discov., 2009, 8, 41-54.
-
(2009)
Nat. Rev. Drug Discov
, vol.8
, pp. 41-54
-
-
Conn, J.P.1
Christopoulus, A.2
Lindsley, C.W.3
-
79
-
-
0035490101
-
Dynamic predictions: Oscillations and synchrony in top-down processing
-
Engel, A. K.; Fries, P.; Singer, W. Dynamic predictions: Oscillations and synchrony in top-down processing. Nat. Rev. Neurosci., 2001, 2, 704-716.
-
(2001)
Nat. Rev. Neurosci
, vol.2
, pp. 704-716
-
-
Engel, A.K.1
Fries, P.2
Singer, W.3
-
80
-
-
33745512492
-
Targeting information-processing deficit in schizophrenia: A novel approach to psychotherapeutic drug discovery
-
Hajos, M. Targeting information-processing deficit in schizophrenia: a novel approach to psychotherapeutic drug discovery. Trends Pharmacol. Sci., 2006, 27, 391-398.
-
(2006)
Trends Pharmacol. Sci
, vol.27
, pp. 391-398
-
-
Hajos, M.1
-
81
-
-
54149092219
-
A Neural Coding Scheme Formed by the Combined Function of Gamma and Theta Oscillations
-
Lisman, J.; Buzsaki, G. A Neural Coding Scheme Formed by the Combined Function of Gamma and Theta Oscillations. Schizophr. Bull., 2008, 34, 974-980.
-
(2008)
Schizophr. Bull
, vol.34
, pp. 974-980
-
-
Lisman, J.1
Buzsaki, G.2
-
82
-
-
84866671224
-
Neuronal Dynamics and Neuropsychiatric Disorders: Toward a Translational Paradigm for Dysfunctional Large-Scale Networks
-
Uhlhaas, P. J.; Singer, W. Neuronal Dynamics and Neuropsychiatric Disorders: Toward a Translational Paradigm for Dysfunctional Large-Scale Networks. Neuron, 2012, 75, 963-980.
-
(2012)
Neuron
, vol.75
, pp. 963-980
-
-
Uhlhaas, P.J.1
Singer, W.2
-
83
-
-
0036305484
-
AMPA receptor trafficking and synaptic plasticity
-
Malinow, R.; Malenka, R. C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci., 2002, 25, 103-126.
-
(2002)
Annu. Rev. Neurosci
, vol.25
, pp. 103-126
-
-
Malinow, R.1
Malenka, R.C.2
-
84
-
-
5344241223
-
LTP and LTD: An Embarrassment of Riches
-
Malenka, R. C.; Bear, M. F. LTP and LTD: An Embarrassment of Riches. Neuron, 2004, 44, 5-21.
-
(2004)
Neuron
, vol.44
, pp. 5-21
-
-
Malenka, R.C.1
Bear, M.F.2
-
85
-
-
0027476024
-
A synaptic model of memory: Long-term potentiation in the hippocampus
-
Bliss, T. V.; Collingridge, G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature, 1993, 361, 31-39.
-
(1993)
Nature
, vol.361
, pp. 31-39
-
-
Bliss, T.V.1
Collingridge, G.L.2
-
86
-
-
38149016966
-
The Cell Biology of Synaptic Plasticity: AMPA Receptor Trafficking
-
Shepherd, J. D.; Huganir, R. L. The Cell Biology of Synaptic Plasticity: AMPA Receptor Trafficking. Annu. Rev. Cell De.v Biol., 2007, 23, 613-643.
-
(2007)
Annu. Rev. Cell De.v Biol
, vol.23
, pp. 613-643
-
-
Shepherd, J.D.1
Huganir, R.L.2
-
87
-
-
33847125205
-
Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death
-
Liu, S. J.; Zukin, R. S. Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death. Trends Neurosci., 2007, 30, 126-134.
-
(2007)
Trends Neurosci
, vol.30
, pp. 126-134
-
-
Liu, S.J.1
Zukin, R.S.2
-
88
-
-
0032192550
-
Neuropharmacology of AMPA and Kainate Receptors
-
Bleakman, D.; Lodge, D. Neuropharmacology of AMPA and Kainate Receptors. Neuropharmacology, 1998, 37, 1187-1204.
-
(1998)
Neuropharmacology
, vol.37
, pp. 1187-1204
-
-
Bleakman, D.1
Lodge, D.2
-
89
-
-
17844407467
-
Therapeutic Potential of Positive AMPA Modulators and Their Relationship to AMPA Receptor Subunits. A Review of Preclinical Data
-
Black, M. D. Therapeutic Potential of Positive AMPA Modulators and Their Relationship to AMPA Receptor Subunits. A Review of Preclinical Data. Psychopharmacology, 2005, 179, 154-163.
-
(2005)
Psychopharmacology
, vol.179
, pp. 154-163
-
-
Black, M.D.1
-
90
-
-
33748762214
-
Ampakines and the threefold path to cognitive enhancement
-
Lynch, G.; Gall, C. Ampakines and the threefold path to cognitive enhancement. Trends Neurosci., 2006, 29, 554-562.
-
(2006)
Trends Neurosci
, vol.29
, pp. 554-562
-
-
Lynch, G.1
Gall, C.2
-
91
-
-
25644454403
-
Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors
-
Jin, R.; Clark, S.; Weeks, A. M.; Dudman, J. T.; Gouaux, E.; Partin, K. M. Mechanism of Positive Allosteric Modulators Acting on AMPA Receptors. J. Neurosci., 2005, 25, 9027-9036.
-
(2005)
J. Neurosci
, vol.25
, pp. 9027-9036
-
-
Jin, R.1
Clark, S.2
Weeks, A.M.3
Dudman, J.T.4
Gouaux, E.5
Partin, K.M.6
-
92
-
-
0028088995
-
Facilitation of Glutamate Receptors Enhances Memory
-
Staubli, U.; Rogers, G.; Lynch, G. Facilitation of Glutamate Receptors Enhances Memory. Proc. Natl. Acad. Sci. U S A., 1994, 91, 777-781.
-
(1994)
Proc. Natl. Acad. Sci. U S A
, vol.91
, pp. 777-781
-
-
Staubli, U.1
Rogers, G.2
Lynch, G.3
-
93
-
-
0027323942
-
Mammalian ionotropic glutamate receptors
-
Wisden, W.; Seeburg, P. H. Mammalian ionotropic glutamate receptors. Curr. Opin. Neurobiol., 1993, 3, 291-298.
-
(1993)
Curr. Opin. Neurobiol
, vol.3
, pp. 291-298
-
-
Wisden, W.1
Seeburg, P.H.2
-
94
-
-
0025804443
-
Glutamate-operated channels: Developmentally early and mature forms arise by alternative splicing
-
Monyer, H.; Seeburg, P. H.; Wisden, W. Glutamate-operated channels: developmentally early and mature forms arise by alternative splicing. Neuron, 1991, 6, 799-810.
-
(1991)
Neuron
, vol.6
, pp. 799-810
-
-
Monyer, H.1
Seeburg, P.H.2
Wisden, W.3
-
95
-
-
0025133397
-
Flip and flop: A cell-specific functional switch in glutamate-operated channels of the CNS
-
Sommer, B.; Keinanen, K.; Verdoorn, T. A.; Wisden, W.; Burnashev, N.; Herb, A.; Kohler, M.; Takagi, T.; Sakmann, B.; Seeburg, P. H. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science, 1990, 249, 1580-1585.
-
(1990)
Science
, vol.249
, pp. 1580-1585
-
-
Sommer, B.1
Keinanen, K.2
Verdoorn, T.A.3
Wisden, W.4
Burnashev, N.5
Herb, A.6
Kohler, M.7
Takagi, T.8
Sakmann, B.9
Seeburg, P.H.10
-
96
-
-
66049091323
-
Flip and flop: A molecular determinant for AMPA receptor channel opening
-
Pei, W.; Huang, Z.; Wang, C.; Han, Y.; Park, J. S.; Niu, L. Flip and flop: a molecular determinant for AMPA receptor channel opening. Biochemistry, 2009, 48, 3767-3777.
-
(2009)
Biochemistry
, vol.48
, pp. 3767-3777
-
-
Pei, W.1
Huang, Z.2
Wang, C.3
Han, Y.4
Park, J.S.5
Niu, L.6
-
97
-
-
2342462388
-
Structure and Function of Glutamate Receptor Ion Channels1
-
Mayer, M. L.; Armstrong, N. Structure and Function of Glutamate Receptor Ion Channels1. Annu. Rev. Physiol., 2004, 66, 161-181.
-
(2004)
Annu. Rev. Physiol
, vol.66
, pp. 161-181
-
-
Mayer, M.L.1
Armstrong, N.2
-
98
-
-
33645321641
-
Glutamate receptors at atomic resolution
-
Mayer, M. L. Glutamate receptors at atomic resolution. Nature, 2006, 440, 456-462.
-
(2006)
Nature
, vol.440
, pp. 456-462
-
-
Mayer, M.L.1
-
99
-
-
72049124287
-
X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor
-
Sobolevsky, A. I.; Rosconi, M. P.; Gouaux, E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature, 2009, 462, 745-756.
-
(2009)
Nature
, vol.462
, pp. 745-756
-
-
Sobolevsky, A.I.1
Rosconi, M.P.2
Gouaux, E.3
-
100
-
-
84876712438
-
-
Patent WO 2007/101116 A2, September 7
-
Gouaux, E.; Song, L.; Xie, Y.; Landry, D.W. GluR2 Receptor Modulators. Patent WO 2007/101116 A2, September 7, 2007.
-
(2007)
GluR2 Receptor Modulators
-
-
Gouaux, E.1
Song, L.2
Xie, Y.3
Landry, D.W.4
-
101
-
-
0043033172
-
Structural basis for partial agonist action at ionotropic glutamate receptors
-
Jin, R.; Banke, T. G.; Mayer, M. L.; Traynelis, S. F.; Gouaux, E. Structural basis for partial agonist action at ionotropic glutamate receptors. Nat Neurosci., 2003, 6, 803-810.
-
(2003)
Nat Neurosci
, vol.6
, pp. 803-810
-
-
Jin, R.1
Banke, T.G.2
Mayer, M.L.3
Traynelis, S.F.4
Gouaux, E.5
-
102
-
-
0033636314
-
Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: Crystal structures of the GluR2 ligand binding core
-
Armstrong, N.; Gouaux, E. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core. Neuron, 2000, 28, 165-218
-
(2000)
Neuron
, vol.28
, pp. 165-218
-
-
Armstrong, N.1
Gouaux, E.2
-
103
-
-
0037118049
-
-
Sun, Y.; Olson, R.; Horning, M.; Armstrong, N.; Mayer, M, Gouaux E. Nature, 2002, 417, 245-253.
-
(2002)
Nature
, vol.417
, pp. 245-253
-
-
Sun, Y.1
Olson, R.2
Horning, M.3
Armstrong, N.4
Mayer, M.5
Gouaux, E.6
-
104
-
-
0029862192
-
AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate
-
Partin, K. M.; Fleck, M. W.; Mayer, M. L. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J. Neurosci., 1996, 16, 6634-6647.
-
(1996)
J. Neurosci
, vol.16
, pp. 6634-6647
-
-
Partin, K.M.1
Fleck, M.W.2
Mayer, M.L.3
-
105
-
-
77949386630
-
Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors
-
Ahmed, A. H.; Oswald, R. E. Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) receptors. J. Med. Chem., 2010, 53, 2197-2203.
-
(2010)
J. Med. Chem
, vol.53
, pp. 2197-2203
-
-
Ahmed, A.H.1
Oswald, R.E.2
-
106
-
-
0036751341
-
LY404187: A novel positive allosteric modulator of AMPA receptors
-
Quirk, J. C.; Nisenbaum, E. S. LY404187: a novel positive allosteric modulator of AMPA receptors. CNS Drug Reviews, 2002, 8, 255-282.
-
(2002)
CNS Drug Reviews
, vol.8
, pp. 255-282
-
-
Quirk, J.C.1
Nisenbaum, E.S.2
-
107
-
-
0027964227
-
Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants
-
Partin, K. M.; Patneau, D. K.; Mayer, M. L. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol. Pharmacol., 1994, 46, 129-138.
-
(1994)
Mol. Pharmacol
, vol.46
, pp. 129-138
-
-
Partin, K.M.1
Patneau, D.K.2
Mayer, M.L.3
-
108
-
-
70149112131
-
Probing the allosteric modulator binding site of GluR2 with thiazide derivatives
-
Ptak, C. P.; Ahmed, A. H.; Oswald, R. E. Probing the allosteric modulator binding site of GluR2 with thiazide derivatives. Biochemistry, 2009, 48, 8594-8602.
-
(2009)
Biochemistry
, vol.48
, pp. 8594-8602
-
-
Ptak, C.P.1
Ahmed, A.H.2
Oswald, R.E.3
-
109
-
-
33644517204
-
Effects of cyclothiazide on GluR1/AMPA receptors
-
Fucile, S.; Miledi, R.; Eusebi, F. Effects of cyclothiazide on GluR1/AMPA receptors. Proc. Natl. Acad. Sci. U S A., 2006, 103, 2943-2947.
-
(2006)
Proc. Natl. Acad. Sci. U S A
, vol.103
, pp. 2943-2947
-
-
Fucile, S.1
Miledi, R.2
Eusebi, F.3
-
110
-
-
0032708893
-
Piracetam in the treatment of schizophrenia: Implications for the glutamate hypothesis of schizophrenia
-
Noorbala, A. A.; Akhondzadeh, S.; Davari-Ashtiani, R.; Amini-Nooshabadi, H. Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia. J. Clin. Pharm. Ther., 1999, 24, 369-374.
-
(1999)
J. Clin. Pharm. Ther
, vol.24
, pp. 369-374
-
-
Noorbala, A.A.1
Akhondzadeh, S.2
Davari-Ashtiani, R.3
Amini-Nooshabadi, H.4
-
111
-
-
0036667175
-
CX-516 Cortex pharmaceuticals
-
Danysz, W. CX-516 Cortex pharmaceuticals. Curr. Opin. Investig. Drugs., 2002, 3, 1081-1088.
-
(2002)
Curr. Opin. Investig. Drugs
, vol.3
, pp. 1081-1088
-
-
Danysz, W.1
-
112
-
-
0036773660
-
Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: A case series
-
Marenco, S.; Egan, M. F.; Goldberg, T. E.; Knable, M. B.; McClure, R. K.; Winterer, G.; Weinberger, D. R. Preliminary experience with an ampakine (CX516) as a single agent for the treatment of schizophrenia: a case series. Schizophr. Res., 2002, 57, 221-226.
-
(2002)
Schizophr. Res
, vol.57
, pp. 221-226
-
-
Marenco, S.1
Egan, M.F.2
Goldberg, T.E.3
Knable, M.B.4
McClure, R.K.5
Winterer, G.6
Weinberger, D.R.7
-
113
-
-
0034796599
-
A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia
-
Goff, D. C.; Leahy, L.; Berman, I.; Posever, T.; Herz, L.; Leon, A. C.; Johnson, S. A.; Lynch, G. A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. J. Clin. Psychopharmacol., 2001, 21, 484-487.
-
(2001)
J. Clin. Psychopharmacol
, vol.21
, pp. 484-487
-
-
Goff, D.C.1
Leahy, L.2
Berman, I.3
Posever, T.4
Herz, L.5
Leon, A.C.6
Johnson, S.A.7
Lynch, G.8
-
114
-
-
38149132338
-
A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia
-
Goff, D. C.; Lamberti, J. S.; Leon, A. C.; Green, M. F.; Miller, A. L.; Patel, J.; Manschreck, T.; Freudenreich, O.; Johnson, S. A. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia. Neuropsychopharmacologyy, 2008, 33, 465-472.
-
(2008)
Neuropsychopharmacologyy
, vol.33
, pp. 465-472
-
-
Goff, D.C.1
Lamberti, J.S.2
Leon, A.C.3
Green, M.F.4
Miller, A.L.5
Patel, J.6
Manschreck, T.7
Freudenreich, O.8
Johnson, S.A.9
-
115
-
-
0028343648
-
Developmental and regional expression in the rat brain and functional properties of four NMDA receptors
-
Monyer, H.; Burnashev, N.; Laurie, D. J.; Sakmann, B.; Seeburg, P. H. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron, 1994, 12, 529-540.
-
(1994)
Neuron
, vol.12
, pp. 529-540
-
-
Monyer, H.1
Burnashev, N.2
Laurie, D.J.3
Sakmann, B.4
Seeburg, P.H.5
-
116
-
-
0026419327
-
Molecular cloning and characterization of the rat NMDA receptor
-
Moriyoshi, K.; Masu, M.; Ishii, T.; Shigemoto, R.; Mizuno, N.; Nakanishi, S. Molecular cloning and characterization of the rat NMDA receptor. Nature, 1991, 354, 31-37.
-
(1991)
Nature
, vol.354
, pp. 31-37
-
-
Moriyoshi, K.1
Masu, M.2
Ishii, T.3
Shigemoto, R.4
Mizuno, N.5
Nakanishi, S.6
-
117
-
-
0035369112
-
NMDA receptor subunits: Diversity, development and disease
-
Cull-Candy, S. G.; Brickley, S.; Farrant, M. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol., 2001, 11, 327-335.
-
(2001)
Curr. Opin. Neurobiol
, vol.11
, pp. 327-335
-
-
Cull-Candy, S.G.1
Brickley, S.2
Farrant, M.3
-
119
-
-
84862171078
-
A history of spike-timing-dependent plasticity
-
Markram, H. A history of spike-timing-dependent plasticity. Front. Synaptic Neurosci., 2011, 3, 1-24.
-
(2011)
Front. Synaptic Neurosci
, vol.3
, pp. 1-24
-
-
Markram, H.1
-
120
-
-
0023915822
-
Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity
-
Cotman, C. W.; Monaghan, D. T.; Ganong, A. H. Excitatory amino acid neurotransmission: NMDA receptors and Hebb-type synaptic plasticity. Annu. Rev. Neurosci., 1988, 11, 61-80.
-
(1988)
Annu. Rev. Neurosci
, vol.11
, pp. 61-80
-
-
Cotman, C.W.1
Monaghan, D.T.2
Ganong, A.H.3
-
121
-
-
0027485836
-
NMDA-receptor-dependent synaptic plasticity: Multiple forms and mechanisms
-
Malenka, R. C.; Nicoll, R. A. NMDA-receptor-dependent synaptic plasticity: multiple forms and mechanisms. Trends Neurosci., 1993, 16, 521-527.
-
(1993)
Trends Neurosci
, vol.16
, pp. 521-527
-
-
Malenka, R.C.1
Nicoll, R.A.2
-
122
-
-
67349136362
-
Role of distinct NMDA receptor subtypes at central synapses
-
Cull-Candy, S. G.; Leszkiewicz, D. N. Role of distinct NMDA receptor subtypes at central synapses. Science STKE, 2004, 16, 1-9.
-
(2004)
Science STKE
, vol.16
, pp. 1-9
-
-
Cull-Candy, S.G.1
Leszkiewicz, D.N.2
-
123
-
-
0027394506
-
Interactions between the glycine and glutamate binding sites of the NMDA receptor
-
Lester, R. A.; Tong, G.; Jahr, C. E. Interactions between the glycine and glutamate binding sites of the NMDA receptor. J. Neurosci., 1993, 13, 1088-1096.
-
(1993)
J. Neurosci
, vol.13
, pp. 1088-1096
-
-
Lester, R.A.1
Tong, G.2
Jahr, C.E.3
-
124
-
-
0027526363
-
Whole cell and single channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization
-
Parsons, C. G.; Zong, X.; Lux, H. D. Whole cell and single channel analysis of the kinetics of glycine-sensitive N-methyl-D-aspartate receptor desensitization. Br. J. Pharmacol., 1993, 109, 213-221.
-
(1993)
Br. J. Pharmacol
, vol.109
, pp. 213-221
-
-
Parsons, C.G.1
Zong, X.2
Lux, H.D.3
-
125
-
-
56049092225
-
Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: The therapeutic potentials for schizophrenia
-
Yang, C. R.; Svensson, K. A. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia. Pharmacol. Ther., 2008, 120, 317-332.
-
(2008)
Pharmacol. Ther
, vol.120
, pp. 317-332
-
-
Yang, C.R.1
Svensson, K.A.2
-
126
-
-
20444391684
-
Glycine transporters: Essential regulators of neurotransmission
-
Eulenburg, V.; Armsen, W.; Betz, H.; Gomeza, J. Glycine transporters: essential regulators of neurotransmission. Trends Biochem. Sci., 2005, 30, 325-333.
-
(2005)
Trends Biochem. Sci
, vol.30
, pp. 325-333
-
-
Eulenburg, V.1
Armsen, W.2
Betz, H.3
Gomeza, J.4
-
127
-
-
0028823737
-
Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells
-
Priestley, T.; Laughton, P.; Myers, J.; Le Bourdelles, B.; Kerby, J.; Whiting, P. J. Pharmacological properties of recombinant human N-methyl-D-aspartate receptors comprising NR1a/NR2A and NR1a/NR2B subunit assemblies expressed in permanently transfected mouse fibroblast cells. Mol. Pharmacol., 1995, 48, 841-848.
-
(1995)
Mol. Pharmacol
, vol.48
, pp. 841-848
-
-
Priestley, T.1
Laughton, P.2
Myers, J.3
Le Bourdelles, B.4
Kerby, J.5
Whiting, P.J.6
-
128
-
-
0028169661
-
Ligand affinities at recombinant Nmethyl-D-aspartate receptors depend on subunit composition
-
Laurie, D. J.; Seeburg, P. H. Ligand affinities at recombinant Nmethyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol., 1994, 268, 335-345.
-
(1994)
Eur. J. Pharmacol
, vol.268
, pp. 335-345
-
-
Laurie, D.J.1
Seeburg, P.H.2
-
129
-
-
84864634182
-
Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists
-
Papouin, T.; Ladepeche, L.; Ruel, J.; Sacchi, S.; Labasque, M.; Hanini, M.; Groc, L.; Pollegioni, L.; Mothet, J. P.; Oliet, S. H. Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists. Cell, 2012, 150, 633-646.
-
(2012)
Cell
, vol.150
, pp. 633-646
-
-
Papouin, T.1
Ladepeche, L.2
Ruel, J.3
Sacchi, S.4
Labasque, M.5
Hanini, M.6
Groc, L.7
Pollegioni, L.8
Mothet, J.P.9
Oliet, S.H.10
-
130
-
-
0025609520
-
Abnormal serine hydroxymethyl transferase activity in the temporal lobes of schizophrenics
-
Waziri, R.; Baruah, S.; Hegwood, T. S.; Sherman, A. D. Abnormal serine hydroxymethyl transferase activity in the temporal lobes of schizophrenics. Neurosci. Lett., 1990, 120, 237-240.
-
(1990)
Neurosci. Lett
, vol.120
, pp. 237-240
-
-
Waziri, R.1
Baruah, S.2
Hegwood, T.S.3
Sherman, A.D.4
-
131
-
-
0027400406
-
Abnormal serine-glycine metabolism in the brains of schizophrenics
-
Waziri, R.; Baruah, S.; Sherman, A. D. Abnormal serine-glycine metabolism in the brains of schizophrenics. Schizophr. Res., 1993, 8, 233-243.
-
(1993)
Schizophr. Res
, vol.8
, pp. 233-243
-
-
Waziri, R.1
Baruah, S.2
Sherman, A.D.3
-
132
-
-
21244442890
-
Dysfunction of glia-neuron communication in pathophysiology of schizophrenia
-
Hashimoto, K.; Shimuzu, E.; Iyo, M. Dysfunction of glia-neuron communication in pathophysiology of schizophrenia. Curr. Psychiatry Rev., 2005, 1, 151-163.
-
(2005)
Curr. Psychiatry Rev
, vol.1
, pp. 151-163
-
-
Hashimoto, K.1
Shimuzu, E.2
Iyo, M.3
-
133
-
-
0037977113
-
Decreased serum levels of Dserine in patients with schizophrenia: Evidence in support of the Nmethyl-D-aspartate receptor hypofunction hypothesis of schizophrenia
-
Hashimoto, K.; Fukushima, T.; Shimizu, E.; Komatsu, N.; Watanabe, H.; Shinoda, N.; Nakazato, M.; Kumakiri, C.; Okada, S.; Hasegawa, H.; Imai, K.; Iyo, M. Decreased serum levels of Dserine in patients with schizophrenia: evidence in support of the Nmethyl-D-aspartate receptor hypofunction hypothesis of schizophrenia. Arch. Gen. Psychiatry, 2003, 60, 572-576.
-
(2003)
Arch. Gen. Psychiatry
, vol.60
, pp. 572-576
-
-
Hashimoto, K.1
Fukushima, T.2
Shimizu, E.3
Komatsu, N.4
Watanabe, H.5
Shinoda, N.6
Nakazato, M.7
Kumakiri, C.8
Okada, S.9
Hasegawa, H.10
Imai, K.11
Iyo, M.12
-
134
-
-
3142737856
-
The NMDA receptor glycine modulatory site: A therapeutic target for improving cognition and reducing negative symptoms in schizophrenia
-
Coyle, J. T.; Tsai, G. The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia. Psychopharmacology (Berl), 2004, 174, 32-38.
-
(2004)
Psychopharmacology (Berl)
, vol.174
, pp. 32-38
-
-
Coyle, J.T.1
Tsai, G.2
-
135
-
-
84859106184
-
Targeting glutamate system for novel antipsychotic approaches: Relevance for residual psychotic symptoms and treatment resistant schizophrenia
-
de Bartolomeis, A.; Sarappa, C.; Magara, S.; Iasevoli, F. Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia. Eur. J. Pharmacol., 2012, 682, 1-11.
-
(2012)
Eur. J. Pharmacol
, vol.682
, pp. 1-11
-
-
de Bartolomeis, A.1
Sarappa, C.2
Magara, S.3
Iasevoli, F.4
-
136
-
-
0348047434
-
Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: A retrospective analysis
-
Heresco-Levy, U.; Javitt, D. C. Comparative effects of glycine and D-cycloserine on persistent negative symptoms in schizophrenia: a retrospective analysis. Schizophr. Res., 2004, 66, 89-96.
-
(2004)
Schizophr. Res
, vol.66
, pp. 89-96
-
-
Heresco-Levy, U.1
Javitt, D.C.2
-
137
-
-
0032925438
-
Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia
-
Heresco-Levy, U.; Javitt, D. C.; Ermilov, M.; Mordel, C.; Silipo, G.; Lichtenstein, M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch. Gen. Psychiatry, 1999, 56, 29-36.
-
(1999)
Arch. Gen. Psychiatry
, vol.56
, pp. 29-36
-
-
Heresco-Levy, U.1
Javitt, D.C.2
Ermilov, M.3
Mordel, C.4
Silipo, G.5
Lichtenstein, M.6
-
138
-
-
18844441253
-
Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results
-
Diaz, P.; Bhaskara, S.; Dursun, S. M.; Deakin, B. Double-blind, placebo-controlled, crossover trial of clozapine plus glycine in refractory schizophrenia negative results. J. Clin. Psychopharmacol., 2005, 25, 277-278.
-
(2005)
J. Clin. Psychopharmacol
, vol.25
, pp. 277-278
-
-
Diaz, P.1
Bhaskara, S.2
Dursun, S.M.3
Deakin, B.4
-
139
-
-
53149109731
-
Serine racemase is predominantly localized in neurons in mouse brain
-
Miya, K.; Inoue, R.; Takata, Y.; Abe, M.; Natsume, R.; Sakimura, K.; Hongou, K.; Miyawaki, T.; Mori, H. Serine racemase is predominantly localized in neurons in mouse brain. J. Comp. Neurol., 2008, 510, 641-654.
-
(2008)
J. Comp. Neurol
, vol.510
, pp. 641-654
-
-
Miya, K.1
Inoue, R.2
Takata, Y.3
Abe, M.4
Natsume, R.5
Sakimura, K.6
Hongou, K.7
Miyawaki, T.8
Mori, H.9
-
140
-
-
58349083854
-
Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors
-
Labrie, V.; Clapcote, S. J.; Roder, J. C. Mutant mice with reduced NMDA-NR1 glycine affinity or lack of D-amino acid oxidase function exhibit altered anxiety-like behaviors. Pharmacol. Biochem. Behav., 2009, 91, 610-620.
-
(2009)
Pharmacol. Biochem. Behav
, vol.91
, pp. 610-620
-
-
Labrie, V.1
Clapcote, S.J.2
Roder, J.C.3
-
141
-
-
43049108742
-
Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia
-
Madeira, C.; Freitas, M.E.; Vargas-Lopes, C.; Wolosker, H.; Panizzutti, R. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr. Res., 2008, 101, 76-83.
-
(2008)
Schizophr. Res
, vol.101
, pp. 76-83
-
-
Madeira, C.1
Freitas, M.E.2
Vargas-Lopes, C.3
Wolosker, H.4
Panizzutti, R.5
-
142
-
-
0027159584
-
Free D-serine, D-aspartate and D alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase
-
Hashimoto, A., Nishikawa, T., Konno, R., Niwa, A., Yasumura, Y., Oka, T. and Takahashi, K. Free D-serine, D-aspartate and D alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase. Neurosci. Lett., 1993, 152, 33-36.
-
(1993)
Neurosci. Lett
, vol.152
, pp. 33-36
-
-
Hashimoto, A.1
Nishikawa, T.2
Konno, R.3
Niwa, A.4
Yasumura, Y.5
Oka, T.6
Takahashi, K.7
-
143
-
-
23044465220
-
Spatial learning and long-term potentiation of mutant mice lacking d-amino-acid oxidase
-
Maekawa, M.; Watanabe, M.; Yamaguchi, S.; Konno, R.; Hori, Y. Spatial learning and long-term potentiation of mutant mice lacking d-amino-acid oxidase. Neurosci. Res., 2005, 53, 34-38.
-
(2005)
Neurosci. Res
, vol.53
, pp. 34-38
-
-
Maekawa, M.1
Watanabe, M.2
Yamaguchi, S.3
Konno, R.4
Hori, Y.5
-
144
-
-
13244260784
-
Mice lacking D-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801
-
Hashimoto, A.; Yoshikawa, M.; Niwa, A.; Konno, R. Mice lacking D-amino acid oxidase activity display marked attenuation of stereotypy and ataxia induced by MK-801. Brain Res., 2005, 1033, 210-215.
-
(2005)
Brain Res
, vol.1033
, pp. 210-215
-
-
Hashimoto, A.1
Yoshikawa, M.2
Niwa, A.3
Konno, R.4
-
145
-
-
67349116852
-
Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine
-
Hashimoto, K.; Fujita, Y.; Horio, M.; Kunitachi, S.; Iyo, M.; Ferraris, D.; Tsukamoto, T. Co-administration of a D-amino acid oxidase inhibitor potentiates the efficacy of D-serine in attenuating prepulse inhibition deficits after administration of dizocilpine. Biol. Psychiatry, 2009, 65, 1103-1106.
-
(2009)
Biol. Psychiatry
, vol.65
, pp. 1103-1106
-
-
Hashimoto, K.1
Fujita, Y.2
Horio, M.3
Kunitachi, S.4
Iyo, M.5
Ferraris, D.6
Tsukamoto, T.7
-
146
-
-
77949447469
-
Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis
-
Tsai, G. E.; Lin, P. Y. Strategies to enhance N-methyl-D-aspartate receptor-mediated neurotransmission in schizophrenia, a critical review and meta-analysis. Curr. Pharm. Des., 2010, 16, 522-537.
-
(2010)
Curr. Pharm. Des
, vol.16
, pp. 522-537
-
-
Tsai, G.E.1
Lin, P.Y.2
-
147
-
-
0034898096
-
Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine
-
Sheinin, A.; Shavit, S.; Benveniste, M. Subunit specificity and mechanism of action of NMDA partial agonist D-cycloserine. Neuropharmacology, 2001, 41, 151-158.
-
(2001)
Neuropharmacology
, vol.41
, pp. 151-158
-
-
Sheinin, A.1
Shavit, S.2
Benveniste, M.3
-
148
-
-
77249087107
-
Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors
-
Dravid, S. M.; Burger, P. B.; Prakash, A.; Geballe, M. T.; Yadav, R.; Le, P.; Vellano, K.; Snyder, J. P.; Traynelis, S. F. Structural determinants of D-cycloserine efficacy at the NR1/NR2C NMDA receptors. J. Neurosci., 2010, 30, 2741-2754.
-
(2010)
J. Neurosci
, vol.30
, pp. 2741-2754
-
-
Dravid, S.M.1
Burger, P.B.2
Prakash, A.3
Geballe, M.T.4
Yadav, R.5
Le, P.6
Vellano, K.7
Snyder, J.P.8
Traynelis, S.F.9
-
149
-
-
0027213413
-
Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene
-
Borowsky, B.; Mezey, E.; Hoffman, B. J. Two glycine transporter variants with distinct localization in the CNS and peripheral tissues are encoded by a common gene. Neuron, 1993, 10, 851-863.
-
(1993)
Neuron
, vol.10
, pp. 851-863
-
-
Borowsky, B.1
Mezey, E.2
Hoffman, B.J.3
-
150
-
-
19544382900
-
Glycine transporters: Crucial roles of pharmacological interest revealed by gene deletion
-
Aragon, C.; Lopez-Corcuera, B. Glycine transporters: crucial roles of pharmacological interest revealed by gene deletion. Trends Pharmacol. Sci., 2005, 26, 283-286.
-
(2005)
Trends Pharmacol. Sci
, vol.26
, pp. 283-286
-
-
Aragon, C.1
Lopez-Corcuera, B.2
-
151
-
-
15244347525
-
Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain
-
Cubelos, B.; Gimenez, C.; Zafra, F. Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain. Cereb. Cortex, 2005, 15, 448-459.
-
(2005)
Cereb. Cortex
, vol.15
, pp. 448-459
-
-
Cubelos, B.1
Gimenez, C.2
Zafra, F.3
-
152
-
-
0029014595
-
Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS
-
Zafra, F.; Gomeza, J.; Olivares, L.; Aragon, C.; Gimenez, C. Regional distribution and developmental variation of the glycine transporters GLYT1 and GLYT2 in the rat CNS. Eur. J. Neurosci., 1995, 7, 1342-1352.
-
(1995)
Eur. J. Neurosci
, vol.7
, pp. 1342-1352
-
-
Zafra, F.1
Gomeza, J.2
Olivares, L.3
Aragon, C.4
Gimenez, C.5
-
153
-
-
0032441894
-
Modulation of N-methyl-D-aspartate receptor function by glycine transport
-
Bergeron, R.; Meyer, T. M.; Coyle, J. T.; Greene, R. W. Modulation of N-methyl-D-aspartate receptor function by glycine transport. Proc. Natl. Acad. Sci. U S A 1998, 95, 15730-15734.
-
(1998)
Proc. Natl. Acad. Sci. U S A
, vol.95
, pp. 15730-15734
-
-
Bergeron, R.1
Meyer, T.M.2
Coyle, J.T.3
Greene, R.W.4
-
154
-
-
10744221393
-
Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition
-
Gomeza, J.; Hulsmann, S.; Ohno, K.; Eulenburg, V.; Szoke, K.; Richter, D.; Betz, H. Inactivation of the glycine transporter 1 gene discloses vital role of glial glycine uptake in glycinergic inhibition. Neuron, 2003, 40, 785-796.
-
(2003)
Neuron
, vol.40
, pp. 785-796
-
-
Gomeza, J.1
Hulsmann, S.2
Ohno, K.3
Eulenburg, V.4
Szoke, K.5
Richter, D.6
Betz, H.7
-
155
-
-
2942590366
-
Gene knockout of glycine transporter 1: Characterization of the behavioral phenotype
-
Tsai, G.; Ralph-Williams, R. J.; Martina, M.; Bergeron, R.; Berger-Sweeney, J.; Dunham, K. S.; Jiang, Z.; Caine, S. B.; Coyle, J. T. Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc. Natl. Acad. Sci. U S A, 2004, 101, 8485-8490.
-
(2004)
Proc. Natl. Acad. Sci. U S A
, vol.101
, pp. 8485-8490
-
-
Tsai, G.1
Ralph-Williams, R.J.2
Martina, M.3
Bergeron, R.4
Berger-Sweeney, J.5
Dunham, K.S.6
Jiang, Z.7
Caine, S.B.8
Coyle, J.T.9
-
156
-
-
36849071470
-
Sarcosine (N-methylglycine) treatment for acute schizophrenia: A randomized, double-blind study
-
Lane, H. Y.; Liu, Y. C.; Huang, C. L.; Chang, Y. C.; Liau, C. H.; Perng, C. H.; Tsai, G. E. Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study. Biol Ps.ychiatry, 2008, 63, 9-12.
-
(2008)
Biol Ps.ychiatry
, vol.63
, pp. 9-12
-
-
Lane, H.Y.1
Liu, Y.C.2
Huang, C.L.3
Chang, Y.C.4
Liau, C.H.5
Perng, C.H.6
Tsai, G.E.7
-
157
-
-
0035206917
-
ALX 5407: A potent, selective inhibitor of the hGlyT1 glycine transporter
-
Atkinson, B. N.; Bell, S. C.; De Vivo, M.; Kowalski, L. R.; Lechner, S. M.; Ognyanov, V. I.; Tham, C. S.; Tsai, C.; Jia, J.; Ashton, D.; Klitenick, M. A. ALX 5407: a potent, selective inhibitor of the hGlyT1 glycine transporter. Mol. Pharmacol, 2001, 60, 1414-1420.
-
(2001)
Mol. Pharmacol
, vol.60
, pp. 1414-1420
-
-
Atkinson, B.N.1
Bell, S.C.2
de Vivo, M.3
Kowalski, L.R.4
Lechner, S.M.5
Ognyanov, V.I.6
Tham, C.S.7
Tsai, C.8
Jia, J.9
Ashton, D.10
Klitenick, M.A.11
-
158
-
-
33646005519
-
Glycine transporter type-1 and its inhibitors
-
Harsing, L. G., Jr.; Juranyi, Z.; Gacsalyi, I.; Tapolcsanyi, P.; Czompa, A.; Matyus, P. Glycine transporter type-1 and its inhibitors. Curr. Med. Chem., 2006, 13, 1017-1044.
-
(2006)
Curr. Med. Chem
, vol.13
, pp. 1017-1044
-
-
Harsing Jr., L.G.1
Juranyi, Z.2
Gacsalyi, I.3
Tapolcsanyi, P.4
Czompa, A.5
Matyus, P.6
-
159
-
-
51049089047
-
Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas
-
Perry, K. W.; Falcone, J. F.; Fell, M. J.; Ryder, J. W.; Yu, H.; Love, P. L.; Katner, J.; Gordon, K. D.; Wade, M. R.; Man, T.; Nomikos, G. G.; Phebus, L. A.; Cauvin, A. J.; Johnson, K. W.; Jones, C. K.; Hoffmann, B. J.; Sandusky, G. E.; Walter, M. W.; Porter, W. J.; Yang, L.; Merchant, K. M.; Shannon, H. E.; Svensson, K. A. Neurochemical and behavioral profiling of the selective GlyT1 inhibitors ALX5407 and LY2365109 indicate a preferential action in caudal vs. cortical brain areas. Neuropharmacology, 2008, 55, 743-754.
-
(2008)
Neuropharmacology
, vol.55
, pp. 743-754
-
-
Perry, K.W.1
Falcone, J.F.2
Fell, M.J.3
Ryder, J.W.4
Yu, H.5
Love, P.L.6
Katner, J.7
Gordon, K.D.8
Wade, M.R.9
Man, T.10
Nomikos, G.G.11
Phebus, L.A.12
Cauvin, A.J.13
Johnson, K.W.14
Jones, C.K.15
Hoffmann, B.J.16
Sandusky, G.E.17
Walter, M.W.18
Porter, W.J.19
Yang, L.20
Merchant, K.M.21
Shannon, H.E.22
Svensson, K.A.23
more..
-
160
-
-
77957801940
-
-
Academic Press (Elsevier): Amsterdam
-
Cioffi, C. L.; Liu, S.; Wolf, M. A. In Annual Reports in Medicinal Chemistry; Academic Press (Elsevier): Amsterdam, 2010, 45, pp.19-35.
-
(2010)
Annual Reports In Medicinal Chemistry
, vol.45
, pp. 19-35
-
-
Cioffi, C.L.1
Liu, S.2
Wolf, M.A.3
-
161
-
-
57349195659
-
Inhibitors of GlyT1 affect glycine transport via discrete binding sites
-
Mezler, M.; Hornberger, W.; Mueller, R.; Schmidt, M.; Amberg, W.; Braje, W.; Ochse, M.; Schoemaker, H.; Behl, B. Inhibitors of GlyT1 affect glycine transport via discrete binding sites. Mol. Pharmacol., 2008, 74, 1705-1715.
-
(2008)
Mol. Pharmacol
, vol.74
, pp. 1705-1715
-
-
Mezler, M.1
Hornberger, W.2
Mueller, R.3
Schmidt, M.4
Amberg, W.5
Braje, W.6
Ochse, M.7
Schoemaker, H.8
Behl, B.9
-
162
-
-
57349094379
-
Design of potent GlyT1 inhibitors: In vitro and in vivo profiles
-
Bridges, T. M.; Williams, R.; Lindsley, C. W. Design of potent GlyT1 inhibitors: in vitro and in vivo profiles. Curr. Opin. Mol. Ther., 2008, 10, 591-601.
-
(2008)
Curr. Opin. Mol. Ther
, vol.10
, pp. 591-601
-
-
Bridges, T.M.1
Williams, R.2
Lindsley, C.W.3
-
163
-
-
3042691500
-
The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors
-
Smith, G.; Ruhland, T.; Mikkelsen, G.; Andersen, K.; Christoffersen, C. T.; Alifrangis, L. H.; Mork, A.; Wren, S. P.; Harris, N.; Wyman, B. M.; Brandt, G. The synthesis and SAR of 2-arylsulfanyl-phenyl piperazinyl acetic acids as glyT-1 inhibitors. Bioorg. Med. Chem. Lett., 2004, 14, 4027-4030.
-
(2004)
Bioorg. Med. Chem. Lett
, vol.14
, pp. 4027-4030
-
-
Smith, G.1
Ruhland, T.2
Mikkelsen, G.3
Andersen, K.4
Christoffersen, C.T.5
Alifrangis, L.H.6
Mork, A.7
Wren, S.P.8
Harris, N.9
Wyman, B.M.10
Brandt, G.11
-
164
-
-
77957789035
-
Effect of the selective glycine reuptake (GlyT-1) inhibitor Org 25935 on glycine levels in CSF and dialysates
-
Andrews, N.; Ge, J.; Walker, G.; Schipper, J.; marston, H. M. Effect of the selective glycine reuptake (GlyT-1) inhibitor Org 25935 on glycine levels in CSF and dialysates. Neuropsychopharmacology, 2007, 17, S497.
-
(2007)
Neuropsychopharmacology
, vol.17
-
-
Andrews, N.1
Ge, J.2
Walker, G.3
Schipper, J.4
Marston, H.M.5
-
165
-
-
84857039780
-
Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: Preliminary evidence
-
D'Souza, D. C.; Singh, N.; Elander, J.; Carbuto, M.; Pittman, B.; de Haes, J. U.; Sjogren, M.; Peeters, P.; Ranganathan, M.; Schipper, J. Glycine transporter inhibitor attenuates the psychotomimetic effects of ketamine in healthy males: preliminary evidence. Neuropsychopharmacology, 2012, 37, 1036-1046.
-
(2012)
Neuropsychopharmacology
, vol.37
, pp. 1036-1046
-
-
D'Souza, D.C.1
Singh, N.2
Elander, J.3
Carbuto, M.4
Pittman, B.5
de Haes, J.U.6
Sjogren, M.7
Peeters, P.8
Ranganathan, M.9
Schipper, J.10
-
166
-
-
29744453122
-
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic
-
Depoortere, R.; Dargazanli, G.; Estenne-Bouhtou, G.; Coste, A.; Lanneau, C.; Desvignes, C.; Poncelet, M.; Heaulme, M.; Santucci, V.; Decobert, M.; Cudennec, A.; Voltz, C.; Boulay, D.; Terranova, J. P.; Stemmelin, J.; Roger, P.; Marabout, B.; Sevrin, M.; Vige, X.; Biton, B.; Steinberg, R.; Francon, D.; Alonso, R.; Avenet, P.; Oury-Donat, F.; Perrault, G.; Griebel, G.; George, P.; Soubrie, P.; Scatton, B. Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic. Neuropsychopharmacology, 2005, 30, 1963-1985.
-
(2005)
Neuropsychopharmacology
, vol.30
, pp. 1963-1985
-
-
Depoortere, R.1
Dargazanli, G.2
Estenne-Bouhtou, G.3
Coste, A.4
Lanneau, C.5
Desvignes, C.6
Poncelet, M.7
Heaulme, M.8
Santucci, V.9
Decobert, M.10
Cudennec, A.11
Voltz, C.12
Boulay, D.13
Terranova, J.P.14
Stemmelin, J.15
Roger, P.16
Marabout, B.17
Sevrin, M.18
Vige, X.19
Biton, B.20
Steinberg, R.21
Francon, D.22
Alonso, R.23
Avenet, P.24
Oury-Donat, F.25
Perrault, G.26
Griebel, G.27
George, P.28
Soubrie, P.29
Scatton, B.30
more..
-
167
-
-
66649086928
-
Mechanism of differential control of NMDA receptor activity by NR2 subunits
-
Gielen, M.; Retchless, B. S.; Mony, L.; Johnson, J. W.; Paoletti, P. Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature, 2009, 459, 703-707.
-
(2009)
Nature
, vol.459
, pp. 703-707
-
-
Gielen, M.1
Retchless, B.S.2
Mony, L.3
Johnson, J.W.4
Paoletti, P.5
-
168
-
-
70349610345
-
Control of NMDA Receptor Function by the NR2 Subunit Amino-Terminal Domain
-
Yuan, H.; Hansen, K. B.; Vance, K. M.; Ogden, K. K.; Traynelis, S. F. Control of NMDA Receptor Function by the NR2 Subunit Amino-Terminal Domain. J. Neurosci., 2009, 29, 12045-12058.
-
(2009)
J. Neurosci
, vol.29
, pp. 12045-12058
-
-
Yuan, H.1
Hansen, K.B.2
Vance, K.M.3
Ogden, K.K.4
Traynelis, S.F.5
-
169
-
-
81755166299
-
New advances in NMDA receptor pharmacology
-
Ogden, K.K.; Traynelis, S.F. New advances in NMDA receptor pharmacology. Trends Pharmacol. Sci., 2011, 32, 726-733.
-
(2011)
Trends Pharmacol. Sci
, vol.32
, pp. 726-733
-
-
Ogden, K.K.1
Traynelis, S.F.2
-
170
-
-
58849138886
-
Structural Basis of NR2B-Selective Antagonist Recognition by N-Methyl-Daspartate Receptors
-
Mony, L.; Krzaczkowski, L.; Leonetti, M.; Le Goff, A.; Alarcon, K.; Neyton, J.; Bertrand, H. O.; Acher, F.; Paoletti, P. Structural Basis of NR2B-Selective Antagonist Recognition by N-Methyl-Daspartate Receptors. Mol. Pharmacol., 2009, 75, 60-74.
-
(2009)
Mol. Pharmacol
, vol.75
, pp. 60-74
-
-
Mony, L.1
Krzaczkowski, L.2
Leonetti, M.3
Le Goff, A.4
Alarcon, K.5
Neyton, J.6
Bertrand, H.O.7
Acher, F.8
Paoletti, P.9
-
171
-
-
38849170353
-
Zinc inhibition of rat NR1/NR2A Nmethyl-D-aspartate receptors
-
Erreger, K.; Traynelis, S. F. Zinc inhibition of rat NR1/NR2A Nmethyl-D-aspartate receptors. J. Physiol., 2008, 586, 763-778.
-
(2008)
J. Physiol
, vol.586
, pp. 763-778
-
-
Erreger, K.1
Traynelis, S.F.2
-
172
-
-
79961020657
-
Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines
-
Mony, L.; Zhu, S.; Carvalho, S.; Paoletti, P. Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines. Embo J., 2011, 30, 3134-3146.
-
(2011)
Embo J
, vol.30
, pp. 3134-3146
-
-
Mony, L.1
Zhu, S.2
Carvalho, S.3
Paoletti, P.4
-
173
-
-
0032914455
-
Antagonists selective for NMDA receptors containing the GLUN2B subunit
-
Chenard, B. L.; Menniti, F. S. Antagonists selective for NMDA receptors containing the GLUN2B subunit. Curr. Pharm. Des., 1999, 5, 381-404.
-
(1999)
Curr. Pharm. Des
, vol.5
, pp. 381-404
-
-
Chenard, B.L.1
Menniti, F.S.2
-
174
-
-
0036250086
-
NR2B selective NMDA receptor antagonists
-
Nikam, S. S.; Meltzer, L. T. NR2B selective NMDA receptor antagonists. Curr. Pharm. Des., 2002, 8, 845-855.
-
(2002)
Curr. Pharm. Des
, vol.8
, pp. 845-855
-
-
Nikam, S.S.1
Meltzer, L.T.2
-
175
-
-
18144428396
-
NR2B subtype-selective NMDA receptor antagonists: 2001-2004
-
McCauley, J. A. NR2B subtype-selective NMDA receptor antagonists: 2001-2004. Expert Opin. Ther. Pat., 2005, 15 389-407.
-
(2005)
Expert Opin. Ther. Pat
, vol.15
, pp. 389-407
-
-
McCauley, J.A.1
-
176
-
-
33646594995
-
Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists
-
Layton, M. E.; Kelly, M. J., 3rd; Rodzinak, K. J. Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists. Curr. Top. Med. Chem., 2006, 6, 697-709.
-
(2006)
Curr. Top. Med. Chem
, vol.6
, pp. 697-709
-
-
Layton, M.E.1
Kelly III, M.J.2
Rodzinak, K.J.3
-
177
-
-
78650649700
-
Insights into Structure-Activity Relationships and CNS Therapeutic Applications of NR2B Selective Antagonists
-
Beinat, C.; Banister, S.; Moussa, I.; Reynolds, A. J.; McErlean, C. S. P.; Kassiou, M. Insights into Structure-Activity Relationships and CNS Therapeutic Applications of NR2B Selective Antagonists. Curr. Med. Chem., 2010, 17, 4166-4190.
-
(2010)
Curr. Med. Chem
, vol.17
, pp. 4166-4190
-
-
Beinat, C.1
Banister, S.2
Moussa, I.3
Reynolds, A.J.4
McErlean, C.S.P.5
Kassiou, M.6
-
178
-
-
80054781460
-
Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators
-
Acker, T. M.; Yuan, H.; Hansen, K. B.; Vance, K. M.; Ogden, K. K.; Jensen, H. S.; Burger, P. B.; Mullasseril, P.; Snyder, J. P.; Liotta, D. C.; Traynelis, S. F. Mechanism for noncompetitive inhibition by novel GluN2C/D N-methyl-D-aspartate receptor subunit-selective modulators. Mol. Pharmacol., 2011, 80, 782-795.
-
(2011)
Mol. Pharmacol
, vol.80
, pp. 782-795
-
-
Acker, T.M.1
Yuan, H.2
Hansen, K.B.3
Vance, K.M.4
Ogden, K.K.5
Jensen, H.S.6
Burger, P.B.7
Mullasseril, P.8
Snyder, J.P.9
Liotta, D.C.10
Traynelis, S.F.11
-
179
-
-
79952411415
-
Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors
-
Hansen, K. B.; Traynelis, S. F. Structural and mechanistic determinants of a novel site for noncompetitive inhibition of GluN2D-containing NMDA receptors. J. Neurosci., 2011, 31, 3650-3661.
-
(2011)
J. Neurosci
, vol.31
, pp. 3650-3661
-
-
Hansen, K.B.1
Traynelis, S.F.2
-
180
-
-
77955365676
-
Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective Nmethyl-D-aspartate receptor antagonists
-
Mosley, C. A.; Acker, T. M.; Hansen, K. B.; Mullasseril, P.; Andersen, K. T.; Le, P.; Vellano, K. M.; Brauner-Osborne, H.; Liotta, D. C.; Traynelis, S. F. Quinazolin-4-one derivatives: A novel class of noncompetitive NR2C/D subunit-selective Nmethyl-D-aspartate receptor antagonists. J. Med. Chem., 2010, 53, 5476-5490.
-
(2010)
J. Med. Chem
, vol.53
, pp. 5476-5490
-
-
Mosley, C.A.1
Acker, T.M.2
Hansen, K.B.3
Mullasseril, P.4
Andersen, K.T.5
Le, P.6
Vellano, K.M.7
Brauner-Osborne, H.8
Liotta, D.C.9
Traynelis, S.F.10
-
181
-
-
84880252318
-
A subunit-selective potentiator of NR2C-and NR2D-containing NMDA receptors
-
Mullasseril, P.; Hansen, K. B.; Vance, K. M.; Ogden, K. K.; Yuan, H.; Kurtkaya, N. L.; Santangelo, R.; Orr, A. G.; Le, P.; Vellano, K. M.; Liotta, D. C.; Traynelis, S. F. A subunit-selective potentiator of NR2C-and NR2D-containing NMDA receptors. Nat. Commun., 2010, 1, 1-8.
-
(2010)
Nat. Commun
, vol.1
, pp. 1-8
-
-
Mullasseril, P.1
Hansen, K.B.2
Vance, K.M.3
Ogden, K.K.4
Yuan, H.5
Kurtkaya, N.L.6
Santangelo, R.7
Orr, A.G.8
Le, P.9
Vellano, K.M.10
Liotta, D.C.11
Traynelis, S.F.12
-
182
-
-
84865746076
-
Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators
-
Monaghan, D. T.; Irvine, M. W.; Costa, B. M.; Fang, G.; Jane, D. E. Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators. Neurochem. Int., 2012, 61, 581-592.
-
(2012)
Neurochem. Int
, vol.61
, pp. 581-592
-
-
Monaghan, D.T.1
Irvine, M.W.2
Costa, B.M.3
Fang, G.4
Jane, D.E.5
-
183
-
-
79960417429
-
Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors
-
Karakas, E.; Simorowski, N.; Furukawa, H. Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptors. Nature, 2011, 475, 249-253.
-
(2011)
Nature
, vol.475
, pp. 249-253
-
-
Karakas, E.1
Simorowski, N.2
Furukawa, H.3
-
184
-
-
72449151659
-
Structure of the zincbound amino-terminal domain of the NMDA receptor NR2B subunit
-
Karakas, E.; Simorowski, N.; Furukawa, H. Structure of the zincbound amino-terminal domain of the NMDA receptor NR2B subunit. Embo J., 2009, 28, 3910-3920.
-
(2009)
Embo J
, vol.28
, pp. 3910-3920
-
-
Karakas, E.1
Simorowski, N.2
Furukawa, H.3
-
185
-
-
84866334439
-
Structural Change of R Domain Heterodimer of NMDA Receptor GluN1 and GluN2B through Binding of Spermine and Ifenprodil
-
Tomitori, H.; Suganami, A.; Saiki, R.; Mizuno, S.; Yoshizawa, Y.; Masuko, T.; Tamura, Y.; Nishimura, K.; Toida, T.; Williams, K.; Kashiwagi, K.; Igarashi, K. Structural Change of R Domain Heterodimer of NMDA Receptor GluN1 and GluN2B through Binding of Spermine and Ifenprodil. J. Pharmacol. Exp. Ther., 2012, 343, 82-90.
-
(2012)
J. Pharmacol. Exp. Ther
, vol.343
, pp. 82-90
-
-
Tomitori, H.1
Suganami, A.2
Saiki, R.3
Mizuno, S.4
Yoshizawa, Y.5
Masuko, T.6
Tamura, Y.7
Nishimura, K.8
Toida, T.9
Williams, K.10
Kashiwagi, K.11
Igarashi, K.12
-
186
-
-
49649122326
-
Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding
-
Marinelli, L.; Cosconati, S.; Steinbrecher, T.; Limongelli, V.; Bertamino, A.; Novellino, E.; Case, D. A. Homology modeling of NR2B modulatory domain of NMDA receptor and analysis of ifenprodil binding. ChemMedChem, 2007, 2, 1498-1510.
-
(2007)
ChemMedChem
, vol.2
, pp. 1498-1510
-
-
Marinelli, L.1
Cosconati, S.2
Steinbrecher, T.3
Limongelli, V.4
Bertamino, A.5
Novellino, E.6
Case, D.A.7
-
187
-
-
77952327490
-
Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists
-
Hansen, K. B.; Mullasseril, P.; Dawit, S.; Kurtkaya, N. L.; Yuan, H.; Vance, K. M.; Orr, A. G.; Kvist, T.; Ogden, K. K.; Le, P.; Vellano, K. M.; Lewis, I.; Kurtkaya, S.; Du, Y.; Qui, M.; Murphy, T. J.; Snyder, J. P.; Brauner-Osborne, H.; Traynelis, S. F. Implementation of a fluorescence-based screening assay identifies histamine H3 receptor antagonists clobenpropit and iodophenpropit as subunit-selective N-methyl-D-aspartate receptor antagonists. J. Pharmacol. Exp. Ther., 2010, 333, 650-662.
-
(2010)
J. Pharmacol. Exp. Ther
, vol.333
, pp. 650-662
-
-
Hansen, K.B.1
Mullasseril, P.2
Dawit, S.3
Kurtkaya, N.L.4
Yuan, H.5
Vance, K.M.6
Orr, A.G.7
Kvist, T.8
Ogden, K.K.9
Le, P.10
Vellano, K.M.11
Lewis, I.12
Kurtkaya, S.13
Du, Y.14
Qui, M.15
Murphy, T.J.16
Snyder, J.P.17
Brauner-Osborne, H.18
Traynelis, S.F.19
-
188
-
-
34047250333
-
Maintenance of superior learning and memory function in NR2B transgenic mice during ageing
-
Cao, X.; Cui, Z.; Feng, R.; Tang, Y. P.; Qin, Z.; Mei, B.; Tsien, J. Z. Maintenance of superior learning and memory function in NR2B transgenic mice during ageing. Eur. J. Neurosci., 2007, 25, 1815-1822.
-
(2007)
Eur. J. Neurosci
, vol.25
, pp. 1815-1822
-
-
Cao, X.1
Cui, Z.2
Feng, R.3
Tang, Y.P.4
Qin, Z.5
Mei, B.6
Tsien, J.Z.7
-
189
-
-
0033517366
-
Genetic enhancement of learning and memory in mice
-
Tang, Y. P.; Shimizu, E.; Dube, G. R.; Rampon, C.; Kerchner, G. A.; Zhuo, M.; Liu, G.; Tsien, J. Z. Genetic enhancement of learning and memory in mice. Nature, 1999, 401, 63-69.
-
(1999)
Nature
, vol.401
, pp. 63-69
-
-
Tang, Y.P.1
Shimizu, E.2
Dube, G.R.3
Rampon, C.4
Kerchner, G.A.5
Zhuo, M.6
Liu, G.7
Tsien, J.Z.8
-
190
-
-
0034793826
-
Differential effects of enrichment on learning and memory function in NR2B transgenic mice
-
Tang, Y. P.; Wang, H.; Feng, R.; Kyin, M.; Tsien, J. Z. Differential effects of enrichment on learning and memory function in NR2B transgenic mice. Neuropharmacology, 2001, 41, 779-790.
-
(2001)
Neuropharmacology
, vol.41
, pp. 779-790
-
-
Tang, Y.P.1
Wang, H.2
Feng, R.3
Kyin, M.4
Tsien, J.Z.5
-
191
-
-
70449397522
-
Genetic enhancement of memory and long-term potentiation but not CA1 long-term depression in NR2B transgenic rats
-
Wang, D.; Cui, Z.; Zeng, Q.; Kuang, H.; Wang, L. P.; Tsien, J. Z.; Cao, X. Genetic enhancement of memory and long-term potentiation but not CA1 long-term depression in NR2B transgenic rats. PLoS One, 2009, 4, e7486.
-
(2009)
PLoS One
, vol.4
-
-
Wang, D.1
Cui, Z.2
Zeng, Q.3
Kuang, H.4
Wang, L.P.5
Tsien, J.Z.6
Cao, X.7
-
192
-
-
77950665251
-
Loss of GluN2B-Containing NMDA Receptors in CA1 Hippocampus and Cortex Impairs Long-Term Depression, Reduces Dendritic Spine Density, and Disrupts Learning
-
Brigman, J. L.; Wright, T.; Talani, G.; Prasad-Mulcare, S.; Jinde, S.; Seabold, G. K.; Mathur, P.; Davis, M. I.; Bock, R.; Gustin, R. M.; Colbran, R. J.; Alvarez, V. A.; Nakazawa, K.; Delpire, E.; Lovinger, D. M.; Holmes, A. Loss of GluN2B-Containing NMDA Receptors in CA1 Hippocampus and Cortex Impairs Long-Term Depression, Reduces Dendritic Spine Density, and Disrupts Learning. J. Neurosci., 2010, 30, 4590-4600.
-
(2010)
J. Neurosci
, vol.30
, pp. 4590-4600
-
-
Brigman, J.L.1
Wright, T.2
Talani, G.3
Prasad-Mulcare, S.4
Jinde, S.5
Seabold, G.K.6
Mathur, P.7
Davis, M.I.8
Bock, R.9
Gustin, R.M.10
Colbran, R.J.11
Alvarez, V.A.12
Nakazawa, K.13
Delpire, E.14
Lovinger, D.M.15
Holmes, A.16
-
193
-
-
57049147406
-
Contribution of Hippocampal and Extra-Hippocampal NR2B-Containing NMDA Receptors to Performance on Spatial Learning Tasks
-
von Engelhardt, J.; Doganci, B.; Jensen, V.; Hvalby, Ø.; Göngrich, C.; Taylor, A.; Barkus, C.; Sanderson, D. J.; Rawlins, J. N. P.; Seeburg, P. H.; Bannerman, D. M.; Monyer, H. Contribution of Hippocampal and Extra-Hippocampal NR2B-Containing NMDA Receptors to Performance on Spatial Learning Tasks. Neuron, 2008, 60, 846-860.
-
(2008)
Neuron
, vol.60
, pp. 846-860
-
-
von Engelhardt, J.1
Doganci, B.2
Jensen, V.3
Hvalby, O.4
Göngrich, C.5
Taylor, A.6
Barkus, C.7
Sanderson, D.J.8
Rawlins, J.N.P.9
Seeburg, P.H.10
Bannerman, D.M.11
Monyer, H.12
-
194
-
-
69749094446
-
NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses
-
Akashi, K.; Kakizaki, T.; Kamiya, H.; Fukaya, M.; Yamasaki, M.; Abe, M.; Natsume, R.; Watanabe, M.; Sakimura, K. NMDA receptor GluN2B (GluR epsilon 2/NR2B) subunit is crucial for channel function, postsynaptic macromolecular organization, and actin cytoskeleton at hippocampal CA3 synapses. J. Neurosci., 2009, 29, 10869-10882.
-
(2009)
J. Neurosci
, vol.29
, pp. 10869-10882
-
-
Akashi, K.1
Kakizaki, T.2
Kamiya, H.3
Fukaya, M.4
Yamasaki, M.5
Abe, M.6
Natsume, R.7
Watanabe, M.8
Sakimura, K.9
-
195
-
-
0036583275
-
A Hippocampal NR2B Deficit Can Mimic Age-Related Changes in Long-Term Potentiation and Spatial Learning in the Fischer 344 Rat
-
Clayton, D. A.; Mesches, M. H.; Alvarez, E.; Bickford, P. C.; Browning, M. D. A Hippocampal NR2B Deficit Can Mimic Age-Related Changes in Long-Term Potentiation and Spatial Learning in the Fischer 344 Rat. J. Neurosci., 2002, 22, 3628-3637.
-
(2002)
J. Neurosci
, vol.22
, pp. 3628-3637
-
-
Clayton, D.A.1
Mesches, M.H.2
Alvarez, E.3
Bickford, P.C.4
Browning, M.D.5
-
196
-
-
1242351945
-
The NMDA receptor NR2B subunit: A valid therapeutic target for multiple CNS pathologies
-
Chazot, P. L. The NMDA receptor NR2B subunit: a valid therapeutic target for multiple CNS pathologies. Curr. Med. Chem., 2004, 11, 389-396.
-
(2004)
Curr. Med. Chem
, vol.11
, pp. 389-396
-
-
Chazot, P.L.1
-
197
-
-
30844451008
-
Glutamate-based therapeutic approaches: NR2B receptor antagonists
-
Gogas, K. R. Glutamate-based therapeutic approaches: NR2B receptor antagonists. Curr Opin. Pharmacol., 2006, 6, 68-74.
-
(2006)
Curr Opin. Pharmacol
, vol.6
, pp. 68-74
-
-
Gogas, K.R.1
-
198
-
-
70350324907
-
Allosteric modulators of NR2B-containing NMDA receptors: Molecular. mechanisms and therapeutic potential
-
Mony, L.; Kew, J. N.; Gunthorpe, M. J.; Paoletti, P. Allosteric modulators of NR2B-containing NMDA receptors: molecular. mechanisms and therapeutic potential. Br. J. Pharmacol., 2009, 157, 1301-1317.
-
(2009)
Br. J. Pharmacol
, vol.157
, pp. 1301-1317
-
-
Mony, L.1
Kew, J.N.2
Gunthorpe, M.J.3
Paoletti, P.4
-
199
-
-
35948933040
-
The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101606 in rats and rhesus monkeys
-
Nicholson, K. L.; Mansbach, R. S.; Menniti, F. S.; Balster, R. L. The phencyclidine-like discriminative stimulus effects and reinforcing properties of the NR2B-selective N-methyl-D-aspartate antagonist CP-101606 in rats and rhesus monkeys. Behav. Pharmacol., 2007, 18, 731-743.
-
(2007)
Behav. Pharmacol
, vol.18
, pp. 731-743
-
-
Nicholson, K.L.1
Mansbach, R.S.2
Menniti, F.S.3
Balster, R.L.4
-
200
-
-
0141757281
-
Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: Preferential involvement of the NR2B rather than NR2A subunit
-
Chaperon, F.; Muller, W.; Auberson, Y. P.; Tricklebank, M. D.; Neijt, H. C. Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit. Behav. Pharmacol., 2003, 14, 477-487.
-
(2003)
Behav. Pharmacol
, vol.14
, pp. 477-487
-
-
Chaperon, F.1
Muller, W.2
Auberson, Y.P.3
Tricklebank, M.D.4
Neijt, H.C.5
-
201
-
-
0029100602
-
(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: A potent new neuroprotectant which blocks N-methyl-D-aspartate responses
-
Chenard, B. L.; Bordner, J.; Butler, T. W.; Chambers, L. K.; Collins, M. A.; De Costa, D. L.; Ducat, M. F.; Dumont, M. L.; Fox, C. B.; Mena, E. E. (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol: a potent new neuroprotectant which blocks N-methyl-D-aspartate responses. J. Med. Chem., 1995, 38, 3138-3145.
-
(1995)
J. Med. Chem
, vol.38
, pp. 3138-3145
-
-
Chenard, B.L.1
Bordner, J.2
Butler, T.W.3
Chambers, L.K.4
Collins, M.A.5
de Costa, D.L.6
Ducat, M.F.7
Dumont, M.L.8
Fox, C.B.9
Mena, E.E.10
-
202
-
-
0030839993
-
CP-101,606, a potent neuroprotectant selective for forebrain neurons-I. Evidence for efficacy in models of focal cerebral ischemia
-
Menniti, F.; Chenard, B.; Collins, M.; Ducat, M.; Shalaby, I.; White, F. CP-101,606, a potent neuroprotectant selective for forebrain neurons-I. Evidence for efficacy in models of focal cerebral ischemia. Eur. J. Pharmacol., 1997, 331, 117-126.
-
(1997)
Eur. J. Pharmacol
, vol.331
, pp. 117-126
-
-
Menniti, F.1
Chenard, B.2
Collins, M.3
Ducat, M.4
Shalaby, I.5
White, F.6
-
203
-
-
0033387727
-
An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage
-
Bullock, M. R.; Merchant, R. E.; Carmack, C. A.; Doppenberg, E.; Shah, A. K.; Wilner, K. D.; Ko, G.; Williams, S. A. An open-label study of CP-101,606 in subjects with a severe traumatic head injury or spontaneous intracerebral hemorrhage. Ann. N Y Acad. Sci., 1999, 890, 51-58.
-
(1999)
Ann. N Y Acad. Sci
, vol.890
, pp. 51-58
-
-
Bullock, M.R.1
Merchant, R.E.2
Carmack, C.A.3
Doppenberg, E.4
Shah, A.K.5
Wilner, K.D.6
Ko, G.7
Williams, S.A.8
-
204
-
-
0033392424
-
A double-blind, placebocontrolled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury
-
Merchant, R. E.; Bullock, M. R.; Carmack, C. A.; Shah, A. K.; Wilner, K. D.; Ko, G.; Williams, S. A. A double-blind, placebocontrolled study of the safety, tolerability and pharmacokinetics of CP-101,606 in patients with a mild or moderate traumatic brain injury. Ann. N Y Acad. Sci., 1999, 890, 42-50.
-
(1999)
Ann. N Y Acad. Sci
, vol.890
, pp. 42-50
-
-
Merchant, R.E.1
Bullock, M.R.2
Carmack, C.A.3
Shah, A.K.4
Wilner, K.D.5
Ko, G.6
Williams, S.A.7
-
205
-
-
59049098262
-
An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatmentrefractory major depressive disorder
-
Preskorn, S. H.; Baker, B.; Kolluri, S.; Menniti, F. S.; Krams, M.; Landen, J. W. An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatmentrefractory major depressive disorder. J. Clin. Psychopharmacol., 2008, 28, 631-637.
-
(2008)
J. Clin. Psychopharmacol
, vol.28
, pp. 631-637
-
-
Preskorn, S.H.1
Baker, B.2
Kolluri, S.3
Menniti, F.S.4
Krams, M.5
Landen, J.W.6
-
206
-
-
78049329316
-
Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes
-
Endele, S.; Rosenberger, G.; Geider, K.; Popp, B.; Tamer, C.; Stefanova, I.; Milh, M.; Kortüm, F.; Fritsch, A.; Pientka, F. K.; Hellenbroich, Y.; Kalscheuer, V. M.; Kohlhase, J.; Moog, U.; Rappold, G.; Rauch, A.; Ropers, H.-H.; von Spiczak, S.; Tönnies, H.; Villeneuve, N.; Villard, L.; Zabel, B.; Zenker, M.; Laube, B.; Reis, A.; Wieczorek, D.; Van Maldergem, L.; Kutsche, K. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes. Nat. Genet., 2010, 42, 1021-1026.
-
(2010)
Nat. Genet
, vol.42
, pp. 1021-1026
-
-
Endele, S.1
Rosenberger, G.2
Geider, K.3
Popp, B.4
Tamer, C.5
Stefanova, I.6
Milh, M.7
Kortüm, F.8
Fritsch, A.9
Pientka, F.K.10
Hellenbroich, Y.11
Kalscheuer, V.M.12
Kohlhase, J.13
Moog, U.14
Rappold, G.15
Rauch, A.16
Ropers, H.-H.17
von Spiczak, S.18
Tönnies, H.19
Villeneuve, N.20
Villard, L.21
Zabel, B.22
Zenker, M.23
Laube, B.24
Reis, A.25
Wieczorek, D.26
van Maldergem, L.27
Kutsche, K.28
more..
-
207
-
-
33846194535
-
Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: A HuGE review and meta-analysis
-
Li, D.; He, L. Association study between the NMDA receptor 2B subunit gene (GRIN2B) and schizophrenia: a HuGE review and meta-analysis. Genet. Med., 2007, 9, 4-8.
-
(2007)
Genet. Med
, vol.9
, pp. 4-8
-
-
Li, D.1
He, L.2
-
208
-
-
9244224117
-
Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors
-
Horak, M.; Vlcek, K.; Petrovic, M.; Chodounska, H.; Vyklicky, L. Jr. Molecular mechanism of pregnenolone sulfate action at NR1/NR2B receptors. J. Neurosci., 2004 24, 10318-10325.
-
(2004)
J. Neurosci
, vol.24
, pp. 10318-10325
-
-
Horak, M.1
Vlcek, K.2
Petrovic, M.3
Chodounska, H.4
Vyklicky Jr., L.5
-
209
-
-
84856448885
-
Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid
-
Costa, B.M.; Irvine, M.W.; Fang, G.; Eaves, R.J.; Mayo-Martin, M.B.; Laube, B.; Jane, D.E.; Monaghan, D.T. Structure-activity relationships for allosteric NMDA receptor inhibitors based on 2-naphthoic acid. Neuropharmacology, 2012, 62, 1730-1736.
-
(2012)
Neuropharmacology
, vol.62
, pp. 1730-1736
-
-
Costa, B.M.1
Irvine, M.W.2
Fang, G.3
Eaves, R.J.4
Mayo-Martin, M.B.5
Laube, B.6
Jane, D.E.7
Monaghan, D.T.8
-
210
-
-
0028867740
-
Glycine-independent and subunit-specific potentiation of NMDA responses by extracellular Mg2+
-
Paoletti, P.; Neyton, J.; Ascher, P. Glycine-independent and subunit-specific potentiation of NMDA responses by extracellular Mg2+. Neuron, 1995, 15, 1109-1120.
-
(1995)
Neuron
, vol.15
, pp. 1109-1120
-
-
Paoletti, P.1
Neyton, J.2
Ascher, P.3
-
211
-
-
0028340993
-
Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits
-
Williams, K.; Zappia, A.M.; Pritchett, D.B.; Shen, Y.M.; Molinoff, P.B. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits. Mol. Pharmacol., 1994, 45, 803-809.
-
(1994)
Mol. Pharmacol
, vol.45
, pp. 803-809
-
-
Williams, K.1
Zappia, A.M.2
Pritchett, D.B.3
Shen, Y.M.4
Molinoff, P.B.5
-
212
-
-
1642452716
-
A molecular mechanism for stabilization of learning-induced synaptic modifications
-
Quinlan, E. M.; Lebel, D.; Brosh, I.; Barkai, E. A molecular mechanism for stabilization of learning-induced synaptic modifications. Neuron, 2004, 41, 185-192.
-
(2004)
Neuron
, vol.41
, pp. 185-192
-
-
Quinlan, E.M.1
Lebel, D.2
Brosh, I.3
Barkai, E.4
-
213
-
-
77953951999
-
Metaplasticity at single glutamatergic synapses
-
Lee, M. C.; Yasuda, R.; Ehlers, M. D. Metaplasticity at single glutamatergic synapses. Neuron, 2010, 66, 859-870.
-
(2010)
Neuron
, vol.66
, pp. 859-870
-
-
Lee, M.C.1
Yasuda, R.2
Ehlers, M.D.3
-
214
-
-
77949420265
-
Promoting neurological recovery of function via metaplasticity
-
Cho, K. K.; Bear, M. F. Promoting neurological recovery of function via metaplasticity. Future Neurol., 2010, 5, 21-26.
-
(2010)
Future Neurol
, vol.5
, pp. 21-26
-
-
Cho, K.K.1
Bear, M.F.2
-
215
-
-
78649580597
-
Identification and characterization of novel NMDA receptor antagonists selective for NR2A-over NR2Bcontaining receptors
-
Bettini, E.; Sava, A.; Griffante, C.; Carignani, C.; Buson, A.; Capelli, A.M.; Negri, M.; Andreetta, F.; Senar-Sancho, S.A.; Guiral, L.; Cardullo, F. Identification and characterization of novel NMDA receptor antagonists selective for NR2A-over NR2Bcontaining receptors. J. Pharmacol. Exp. Ther., 2010, 335, 636-644.
-
(2010)
J. Pharmacol. Exp. Ther
, vol.335
, pp. 636-644
-
-
Bettini, E.1
Sava, A.2
Griffante, C.3
Carignani, C.4
Buson, A.5
Capelli, A.M.6
Negri, M.7
Andreetta, F.8
Senar-Sancho, S.A.9
Guiral, L.10
Cardullo, F.11
-
216
-
-
79953199424
-
Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses
-
Rauner, C.; Kohr, G. Triheteromeric NR1/NR2A/NR2B receptors constitute the major N-methyl-D-aspartate receptor population in adult hippocampal synapses. J. Biol. Chem. 2011, 286, 7558-7566.
-
(2011)
J. Biol. Chem
, vol.286
, pp. 7558-7566
-
-
Rauner, C.1
Kohr, G.2
-
217
-
-
17444426068
-
Modulation of triheteromeric NMDA receptors by N-terminal domain ligands
-
Hatton, C.J.; Paoletti, P. Modulation of triheteromeric NMDA receptors by N-terminal domain ligands. Neuron., 2005, 46(2), 261-274.
-
(2005)
Neuron
, vol.46
, Issue.2
, pp. 261-274
-
-
Hatton, C.J.1
Paoletti, P.2
-
218
-
-
33646551184
-
Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia
-
Lindsley, C. W.; Shipe, W. D.; Wolkenberg, S. E.; Theberge, C. R.; Williams, D. L., Jr.; Sur, C.; Kinney, G. G. Progress towards validating the NMDA receptor hypofunction hypothesis of schizophrenia. Curr. Top. Med. Chem., 2006, 6, 771-785.
-
(2006)
Curr. Top. Med. Chem
, vol.6
, pp. 771-785
-
-
Lindsley, C.W.1
Shipe, W.D.2
Wolkenberg, S.E.3
Theberge, C.R.4
Williams Jr., D.L.5
Sur, C.6
Kinney, G.G.7
-
219
-
-
84856120944
-
From revolution to evolution: The glutamate hypothesis of schizophrenia and its implication for treatment
-
Moghaddam, B.; Javitt, D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology, 2012, 37, 4-15.
-
(2012)
Neuropsychopharmacology
, vol.37
, pp. 4-15
-
-
Moghaddam, B.1
Javitt, D.2
-
220
-
-
58149119377
-
Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
-
Conn, P. J.; Lindsley, C. W.; Jones, C. K. Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia. Trends Pharmacol. Sci., 2009, 30, 25-31.
-
(2009)
Trends Pharmacol. Sci
, vol.30
, pp. 25-31
-
-
Conn, P.J.1
Lindsley, C.W.2
Jones, C.K.3
-
221
-
-
84857375139
-
Allosteric modulation of seven transmembrane spanning receptors: Theory, practice, and opportunities for central nervous system drug discovery
-
Melancon, B. J.; Hopkins, C. R.; Wood, M. R.; Emmitte, K. A.; Niswender, C. M.; Christopoulos, A.; Conn, P. J.; Lindsley, C. W. Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery. J. Med. Chem., 2012, 55, 1445-1464.
-
(2012)
J. Med. Chem
, vol.55
, pp. 1445-1464
-
-
Melancon, B.J.1
Hopkins, C.R.2
Wood, M.R.3
Emmitte, K.A.4
Niswender, C.M.5
Christopoulos, A.6
Conn, P.J.7
Lindsley, C.W.8
-
222
-
-
53449093828
-
G-protein-coupled receptors: From classical modes of modulation to allosteric mechanisms
-
Bridges, T. M.; Lindsley, C. W. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms. ACS Chem. Biol., 2008, 3, 530-541.
-
(2008)
ACS Chem. Biol
, vol.3
, pp. 530-541
-
-
Bridges, T.M.1
Lindsley, C.W.2
-
223
-
-
42149181885
-
Structural diversity of G proteincoupled receptors and significance for drug discovery
-
Lagerstrom, M. C.; Schioth, H. B. Structural diversity of G proteincoupled receptors and significance for drug discovery. Nat. Rev. Drug Discov., 2008, 7, 339-357.
-
(2008)
Nat. Rev. Drug Discov
, vol.7
, pp. 339-357
-
-
Lagerstrom, M.C.1
Schioth, H.B.2
-
224
-
-
84863255255
-
Structure and ligand recognition of class C GPCRs
-
Chun, L.; Zhang, W. H.; Liu, J. F. Structure and ligand recognition of class C GPCRs. Acta Pharmacol. Sin., 2012, 33, 312-323.
-
(2012)
Acta Pharmacol. Sin
, vol.33
, pp. 312-323
-
-
Chun, L.1
Zhang, W.H.2
Liu, J.F.3
-
225
-
-
0036258990
-
G protein-coupled receptor allosterism and complexing
-
Christopoulos, A.; Kenakin, T. G protein-coupled receptor allosterism and complexing. Pharmacol. Rev., 2002, 54, 323-374.
-
(2002)
Pharmacol. Rev
, vol.54
, pp. 323-374
-
-
Christopoulos, A.1
Kenakin, T.2
-
226
-
-
69649097791
-
7TM receptor allostery: Putting numbers to shapeshifting proteins
-
Kenakin, T. P. 7TM receptor allostery: putting numbers to shapeshifting proteins. Trends Pharmacol. Sci., 2009, 30, 460-469.
-
(2009)
Trends Pharmacol. Sci
, vol.30
, pp. 460-469
-
-
Kenakin, T.P.1
-
227
-
-
33747181100
-
Allosteric agonists of 7TM receptors: Expanding the pharmacological toolbox
-
Langmead, C. J.; Christopoulos, A. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox. Trends Pharmacol. Sci., 2006, 27, 475-481.
-
(2006)
Trends Pharmacol. Sci
, vol.27
, pp. 475-481
-
-
Langmead, C.J.1
Christopoulos, A.2
-
228
-
-
33847122495
-
Allosteric modulation of G protein-coupled receptors
-
May, L. T.; Leach, K.; Sexton, P. M.; Christopoulos, A. Allosteric modulation of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol., 2007, 47, 1-51.
-
(2007)
Annu. Rev. Pharmacol. Toxicol
, vol.47
, pp. 1-51
-
-
May, L.T.1
Leach, K.2
Sexton, P.M.3
Christopoulos, A.4
-
229
-
-
44949181722
-
Allosteric modulation of kinases and GPCRs: Design principles and structural diversity
-
Lewis, J. A.; Lebois, E. P.; Lindsley, C. W. Allosteric modulation of kinases and GPCRs: design principles and structural diversity. Curr. Opin. Chem. Biol., 2008, 12, 269-280.
-
(2008)
Curr. Opin. Chem. Biol
, vol.12
, pp. 269-280
-
-
Lewis, J.A.1
Lebois, E.P.2
Lindsley, C.W.3
-
230
-
-
0036490942
-
Allosteric binding sites on cell surface receptors: Novel targets for drug discovery
-
Christopoulos, A. Allosteric binding sites on cell surface receptors: novel targets for drug discovery. Nat. Rev. Drug Discov. 2002, 1, 198-210.
-
(2002)
Nat. Rev. Drug Discov
, vol.1
, pp. 198-210
-
-
Christopoulos, A.1
-
231
-
-
77949516412
-
Metabotropic glutamate receptors: Physiology, pharmacology, and disease
-
Niswender, C. M.; Conn, P. J. Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu. Rev. Pharmacol. Toxicol., 2010, 50, 295-322.
-
(2010)
Annu. Rev. Pharmacol. Toxicol
, vol.50
, pp. 295-322
-
-
Niswender, C.M.1
Conn, P.J.2
-
232
-
-
78649909134
-
An industrial perspective on positive allosteric modulation as a means to discover safe and selective drugs
-
Rocheville, M.; Garland, S.L. An industrial perspective on positive allosteric modulation as a means to discover safe and selective drugs. Drug Discov. Today Technol., 2010, 7, e87-e94.
-
(2010)
Drug Discov. Today Technol
, vol.7
-
-
Rocheville, M.1
Garland, S.L.2
-
233
-
-
79955710801
-
Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder
-
Frank, R. A. Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder. PLoS One, 2011, 6, e19011.
-
(2011)
PLoS One
, vol.6
-
-
Frank, R.A.1
-
234
-
-
84858651719
-
Deleterious GRM1mutations n schizophrenia
-
Ayoub, M. A. Deleterious GRM1mutations n schizophrenia. PLoS One, 2012, 7, e32849.
-
(2012)
PLoS One
, vol.7
-
-
Ayoub, M.A.1
-
235
-
-
80051740508
-
Recent advances in the medicinal chemistry of the metabotropic glutamate receptor 1 (mGlu(1))
-
Owen, D. R. Recent advances in the medicinal chemistry of the metabotropic glutamate receptor 1 (mGlu(1)). ACS Chem. Neurosci., 2011, 2, 394-401.
-
(2011)
ACS Chem. Neurosci
, vol.2
, pp. 394-401
-
-
Owen, D.R.1
-
236
-
-
24644520313
-
Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5)
-
Williams, D. L., Jr.; Lindsley, C. W. Discovery of positive allosteric modulators of metabotropic glutamate receptor subtype 5 (mGluR5). Curr. Top. Med. Chem., 2005, 5, 825-846.
-
(2005)
Curr. Top. Med. Chem
, vol.5
, pp. 825-846
-
-
Williams Jr., D.L.1
Lindsley, C.W.2
-
237
-
-
80051728277
-
Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu(5))
-
Stauffer, S. R. Progress toward positive allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu(5)). ACS Chem. Neurosci., 2011, 2, 450-470.
-
(2011)
ACS Chem. Neurosci
, vol.2
, pp. 450-470
-
-
Stauffer, S.R.1
-
238
-
-
11144354887
-
A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain
-
O'Brien, J. A.; Lemaire, W.; Wittmann, M.; Jacobson, M. A.; Ha, S. N.; Wisnoski, D. D.; Lindsley, C. W.; Schaffhauser, H. J.; Rowe, B.; Sur, C.; Duggan, M. E.; Pettibone, D. J.; Conn, P. J.; Williams, D. L., Jr. A novel selective allosteric modulator potentiates the activity of native metabotropic glutamate receptor subtype 5 in rat forebrain. J. Pharmacol. Exp. Ther., 2004, 309, 568-577.
-
(2004)
J. Pharmacol. Exp. Ther
, vol.309
, pp. 568-577
-
-
O'Brien, J.A.1
Lemaire, W.2
Wittmann, M.3
Jacobson, M.A.4
Ha, S.N.5
Wisnoski, D.D.6
Lindsley, C.W.7
Schaffhauser, H.J.8
Rowe, B.9
Sur, C.10
Duggan, M.E.11
Pettibone, D.J.12
Conn, P.J.13
Williams Jr., D.L.14
-
239
-
-
33846936284
-
Challenges in the development of mGluR5 positive allosteric modulators: The discovery of CPPHA
-
Zhao, Z.; Wisnoski, D. D.; O'Brien, J. A.; Lemaire, W.; Williams, D. L., Jr.; Jacobson, M. A.; Wittman, M.; Ha, S. N.; Schaffhauser, H.; Sur, C.; Pettibone, D. J.; Duggan, M. E.; Conn, P. J.; Hartman, G. D.; Lindsley, C. W. Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA. Bioorg. Med. Chem. Lett., 2007, 17, 1386-1391.
-
(2007)
Bioorg. Med. Chem. Lett
, vol.17
, pp. 1386-1391
-
-
Zhao, Z.1
Wisnoski, D.D.2
O'Brien, J.A.3
Lemaire, W.4
Williams Jr., D.L.5
Jacobson, M.A.6
Wittman, M.7
Ha, S.N.8
Schaffhauser, H.9
Sur, C.10
Pettibone, D.J.11
Duggan, M.E.12
Conn, P.J.13
Hartman, G.D.14
Lindsley, C.W.15
-
240
-
-
84870250543
-
Discovery and SAR of a novel series of non-MPEP site mGlu(5) PAMs based on an aryl glycine sulfonamide scaffold
-
Rodriguez, A.L.; Zhou, Y.; Williams, R.; David, Weaver C.; Vinson, P.N.; Dawson, E.S.; Steckler, T.; Lavreysen, H.; Mackie, C.; Bartolomé, J.M.; Macdonald, G.J.; Scott Daniels, J.; Niswender, C.M.; Jones, C.K.; Jeffrey Conn, P.; Lindsley, C.W.; Stauffer, S.R. Discovery and SAR of a novel series of non-MPEP site mGlu(5) PAMs based on an aryl glycine sulfonamide scaffold. Bioorg. Med. Chem. Lett., 2012, 22, 7388-7392.
-
(2012)
Bioorg. Med. Chem. Lett
, vol.22
, pp. 7388-7392
-
-
Rodriguez, A.L.1
Zhou, Y.2
Williams, R.3
David, W.C.4
Vinson, P.N.5
Dawson, E.S.6
Steckler, T.7
Lavreysen, H.8
Mackie, C.9
Bartolomé, J.M.10
Macdonald, G.J.11
Scott Daniels, J.12
Niswender, C.M.13
Jones, C.K.14
Jeffrey Conn, P.15
Lindsley, C.W.16
Stauffer, S.R.17
-
241
-
-
77958485620
-
Discovery of a novel chemical class of mGlu(5) allosteric ligands with distinct modes of pharmacology
-
Hammond, A. S.; Rodriguez, A. L.; Townsend, S. D.; Niswender, C. M.; Gregory, K. J.; Lindsley, C. W.; Conn, P. J. Discovery of a novel chemical class of mGlu(5) allosteric ligands with distinct modes of pharmacology. ACS Chem. Neurosci., 2010, 1, 702-716.
-
(2010)
ACS Chem. Neurosci
, vol.1
, pp. 702-716
-
-
Hammond, A.S.1
Rodriguez, A.L.2
Townsend, S.D.3
Niswender, C.M.4
Gregory, K.J.5
Lindsley, C.W.6
Conn, P.J.7
-
242
-
-
27744558560
-
Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes
-
Zhang, Y.; Rodriguez, A. L.; Conn, P. J. Allosteric potentiators of metabotropic glutamate receptor subtype 5 have differential effects on different signaling pathways in cortical astrocytes. J. Pharmacol. Exp. Ther., 2005, 315, 1212-1219.
-
(2005)
J. Pharmacol. Exp. Ther
, vol.315
, pp. 1212-1219
-
-
Zhang, Y.1
Rodriguez, A.L.2
Conn, P.J.3
-
243
-
-
47149106805
-
Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: Unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold
-
Sharma, S.; Rodriguez, A. L.; Conn, P. J.; Lindsley, C. W. Synthesis and SAR of a mGluR5 allosteric partial antagonist lead: unexpected modulation of pharmacology with slight structural modifications to a 5-(phenylethynyl)pyrimidine scaffold. Bioorg. Med. Chem. Lett., 2008, 18, 4098-4101.
-
(2008)
Bioorg. Med. Chem. Lett
, vol.18
, pp. 4098-4101
-
-
Sharma, S.1
Rodriguez, A.L.2
Conn, P.J.3
Lindsley, C.W.4
-
244
-
-
79953213637
-
Molecular switches on mGluR allosteric ligands that modulate modes of pharmacology
-
Wood, M. R.; Hopkins, C. R.; Brogan, J. T.; Conn, P. J.; Lindsley, C. W. Molecular switches on mGluR allosteric ligands that modulate modes of pharmacology. Biochemistry, 2011, 50, 2403-2410.
-
(2011)
Biochemistry
, vol.50
, pp. 2403-2410
-
-
Wood, M.R.1
Hopkins, C.R.2
Brogan, J.T.3
Conn, P.J.4
Lindsley, C.W.5
-
245
-
-
0031055985
-
LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors
-
Schoepp, D. D.; Johnson, B. G.; Wright, R. A.; Salhoff, C. R.; Mayne, N. G.; Wu, S.; Cockerman, S. L.; Burnett, J. P.; Belegaje, R.; Bleakman, D.; Monn, J. A. LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors. Neuropharmacology, 1997, 36, 1-11.
-
(1997)
Neuropharmacology
, vol.36
, pp. 1-11
-
-
Schoepp, D.D.1
Johnson, B.G.2
Wright, R.A.3
Salhoff, C.R.4
Mayne, N.G.5
Wu, S.6
Cockerman, S.L.7
Burnett, J.P.8
Belegaje, R.9
Bleakman, D.10
Monn, J.A.11
-
246
-
-
0032575715
-
Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats
-
Moghaddam, B.; Adams, B. W. Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats. Science, 1998, 281, 1349-1352.
-
(1998)
Science
, vol.281
, pp. 1349-1352
-
-
Moghaddam, B.1
Adams, B.W.2
-
247
-
-
34948858402
-
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: A randomized Phase 2 clinical trial
-
Patil, S. T.; Zhang, L.; Martenyi, F.; Lowe, S. L.; Jackson, K. A.; Andreev, B. V.; Avedisova, A. S.; Bardenstein, L. M.; Gurovich, I. Y.; Morozova, M. A.; Mosolov, S. N.; Neznanov, N. G.; Reznik, A. M.; Smulevich, A. B.; Tochilov, V. A.; Johnson, B. G.; Monn, J. A.; Schoepp, D. D. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nat. Med., 2007, 13, 1102-1107.
-
(2007)
Nat. Med
, vol.13
, pp. 1102-1107
-
-
Patil, S.T.1
Zhang, L.2
Martenyi, F.3
Lowe, S.L.4
Jackson, K.A.5
Andreev, B.V.6
Avedisova, A.S.7
Bardenstein, L.M.8
Gurovich, I.Y.9
Morozova, M.A.10
Mosolov, S.N.11
Neznanov, N.G.12
Reznik, A.M.13
Smulevich, A.B.14
Tochilov, V.A.15
Johnson, B.G.16
Monn, J.A.17
Schoepp, D.D.18
-
248
-
-
20944439080
-
Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects
-
Krystal, J. H.; Abi-Saab, W.; Perry, E.; D'Souza, D. C.; Liu, N.; Gueorguieva, R.; McDougall, L.; Hunsberger, T.; Belger, A.; Levine, L.; Breier, A. Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects. Psychopharmacology, 2005, 179, 303-309.
-
(2005)
Psychopharmacology
, vol.179
, pp. 303-309
-
-
Krystal, J.H.1
Abi-Saab, W.2
Perry, E.3
D'Souza, D.C.4
Liu, N.5
Gueorguieva, R.6
McDougall, L.7
Hunsberger, T.8
Belger, A.9
Levine, L.10
Breier, A.11
-
249
-
-
79955594301
-
A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia
-
Kinon, B. J.; Zhang, L.; Millen, B. A.; Osuntokun, O. O.; Williams, J. E.; Kollack-Walker, S.; Jackson, K.; Kryzhanovskaya, L.; Jarkova, N. A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia. J. Clin. Psychopharmacol., 2011, 31, 349-355.
-
(2011)
J. Clin. Psychopharmacol
, vol.31
, pp. 349-355
-
-
Kinon, B.J.1
Zhang, L.2
Millen, B.A.3
Osuntokun, O.O.4
Williams, J.E.5
Kollack-Walker, S.6
Jackson, K.7
Kryzhanovskaya, L.8
Jarkova, N.9
-
250
-
-
80051770211
-
Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators
-
Sheffler, D. J.; Pinkerton, A. B.; Dahl, R.; Markou, A.; Cosford, N. D. Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators. ACS Chem. Neurosci., 2011, 2, 382-393.
-
(2011)
ACS Chem. Neurosci
, vol.2
, pp. 382-393
-
-
Sheffler, D.J.1
Pinkerton, A.B.2
Dahl, R.3
Markou, A.4
Cosford, N.D.5
-
251
-
-
0034029845
-
Neurocognitive deficits and functional outcome in schizophrenia: Are we measuring the right stuff?
-
Green, M. F.; Kern, R. S.; Braff, D. L.; Mintz, J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the right stuff? Schizophr. Bull., 2000, 26, 119-136.
-
(2000)
Schizophr. Bull
, vol.26
, pp. 119-136
-
-
Green, M.F.1
Kern, R.S.2
Braff, D.L.3
Mintz, J.4
-
252
-
-
80052514046
-
The NIMH-CATIE Schizophrenia Study: What Did We Learn?
-
Lieberman, J. A.; Stroup, T. S. The NIMH-CATIE Schizophrenia Study: What Did We Learn? Am. J. Psychiatry, 2011, 168, 770-775.
-
(2011)
Am. J. Psychiatry
, vol.168
, pp. 770-775
-
-
Lieberman, J.A.1
Stroup, T.S.2
-
253
-
-
33749321169
-
Randomized controlled trial of the effect on Quality of Life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1)
-
Jones, P. B.; Barnes, T. R.; Davies, L.; Dunn, G.; Lloyd, H.; Hayhurst, K. P.; Murray, R. M.; Markwick, A.; Lewis, S. W. Randomized controlled trial of the effect on Quality of Life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch. Gen. Psychiatry, 2006, 63, 1079-1087.
-
(2006)
Arch. Gen. Psychiatry
, vol.63
, pp. 1079-1087
-
-
Jones, P.B.1
Barnes, T.R.2
Davies, L.3
Dunn, G.4
Lloyd, H.5
Hayhurst, K.P.6
Murray, R.M.7
Markwick, A.8
Lewis, S.W.9
-
254
-
-
33644994132
-
Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: An exploratory analysis of headto-head comparison studies of second-generation antipsychotics
-
Heres, S.; Davis, J.; Maino, K.; Jetzinger, E.; Kissling, W.; Leucht, S. Why olanzapine beats risperidone, risperidone beats quetiapine, and quetiapine beats olanzapine: an exploratory analysis of headto-head comparison studies of second-generation antipsychotics. Am. J. Psychiatry, 2006, 163, 185-194.
-
(2006)
Am. J. Psychiatry
, vol.163
, pp. 185-194
-
-
Heres, S.1
Davis, J.2
Maino, K.3
Jetzinger, E.4
Kissling, W.5
Leucht, S.6
-
255
-
-
81755184126
-
Allo-network drugs: Harnessing allostery in cellular networks
-
Nussinov, R.; Tsai, C. J.; Csermely, P. Allo-network drugs: harnessing allostery in cellular networks. Trends Pharmacol. Sci., 2011, 32, 686-693.
-
(2011)
Trends Pharmacol. Sci
, vol.32
, pp. 686-693
-
-
Nussinov, R.1
Tsai, C.J.2
Csermely, P.3
|